Medical specialties, branches of medicine Books

Book SynopsisThis book explains all of the stages involved in developing medical devices; from concept to medical approval including system engineering, bioinstrumentation design, signal processing, electronics, software and ICT with Cloud and e-Health development. Medical Instrument Design and Development offers a comprehensive theoretical background with extensive use of diagrams, graphics and tables (around 400 throughout the book). The book explains how the theory is translated into industrial medical products using a market-sold Electrocardiograph disclosed in its design by the Gamma Cardio Soft manufacturer. The sequence of the chapters reflects the product development lifecycle. Each chapter is focused on a specific University course and is divided into two sections: theory and implementation. The theory sections explain the main concepts and principles which remain valid across technological evolutions of medical instrumentation. The Implementation sections show how the theoryTable of ContentsForeword xv Preface xvii Acknowledgment xxi 1 System Engineering 1 Chapter Organization 1 Part I: Theory 4 1.1 Introduction 4 1.2 Problem Formulation in Product Design 4 1.3 The Business Context for Design 6 1.4 The Engineering Product Design Process 10 1.5 System-subsystem Decomposition 15 1.6 The Product Development Life Cycle 21 1.7 Project Management in Product Design 24 1.8 Intellectual Property Rights and Reuse 30 Part II: Implementation 32 1.11 The ECG: Introduction 32 1.11.1 The ECG’s diagnostic relevance 32 1.11.2 ECG Types 33 1.12 The ECG Design Problem Formulation 34 1.13 The ECG Business Plan 36 1.13.1 Market Size and Trend 37 1.13.2 Core and Distinctive Features 38 1.14 The ECG Design Process 40 1.14.1 Transverse Activities of the ECG Design Process 43 1.14.2 Core Activities of the ECG Design Process 44 1.15 ECG System–subsystem Decomposition 44 1.15.1 Hardware Platform Decomposition 45 1.15.2 Software Application Decomposition 45 1.16 ECG Product Life Cycle 46 1.16.1 Overcoming Risk of Inadequate Visualization of ECG Signal 47 1.16.2 Overcoming Risk of Error Fixing in System Integration 50 1.16.3 Overcoming Risks for Non-stable/Unfeasible Requirements 50 1.17 The ECG Development Plan and Project Management 51 1.18 IPR and Reuse Strategy for the ECG 55 References 57 2 Concepts and Requirements 59 Chapter Organization 59 Part I: Theory 61 2.1 Introduction 61 2.2 The Medical Instrumentation Approach 62 2.3 Extraction of Physiological Parameters 67 2.4 Pressure and Flow 70 2.4.1 Blood Pressure 72 2.4.2 Blood Flow and Hemodynamics 74 2.5 Biopotential Recording 79 2.6 Electroencephalography 81 2.7 Electromyography 85 Part II: Implementation 88 2.8 Introduction 88 2.9 Requirements Management 89 2.10 Medical Instruments Requirements and Standards 91 2.11 ECG Requirements 94 2.12 The Patient Component 96 2.12.1 The Heart’s Pumping Function and the Circulatory System 96 2.12.2 Heart Conduction ‘Control’ System 97 2.13 The ECG Method for Observation 99 2.13.1 Recording the Heart’s Electrical Signals 99 2.13.2 ECG Definition and History 103 2.13.3 ECG Standard Method of Observation 103 2.14 Features of the Observations 108 2.14.1 ECG Signal 108 2.14.2 Clinically Significant Signal 110 2.14.3 Power Line Noise 117 2.14.4 Isoelectric Line Instability 118 2.14.5 Muscle Artifacts 119 2.15 Requirements Related to Measurements 119 2.16 Safety Requirements 126 2.16.1 EMC Performance 128 2.17 Usability and Marketing Requirements 131 2.18 Environment Issues 132 2.19 Economic Requirements 134 References 135 3 Biomedical Engineering Design 137 Chapter Organization 138 Part I: Theory 139 3.1 Design Principles and Regulations 139 3.2 General Design System Model 141 3.3 Pressure and Flow Instruments 142 3.3.1 Blood Pressure Instruments 144 3.3.2 Flow Measurements 146 3.3.3 Measuring Oxygen Concentration 147 3.4 Biopotential Instruments 148 3.4.1 Electroencephalographs 148 3.4.2 Electromyographs 151 3.5 The Design Process 152 3.5.1 The Conceptual Design 155 3.5.2 System-wide Design Decisions 156 3.5.3 System Architectural Design 157 3.5.4 Risk Management 157 Part II: Implementation 160 3.6 ECG-wide Decisions 160 3.6.1 The Gamma Cardio CG Use Case 160 3.6.2 Human Factors and the User Interface Design 161 3.6.3 Patient Interface: the Biopotential Electrodes 167 3.7 The ECG System Architectural Design 170 3.7.1 Subsystem Identification 170 3.7.2 The Communication Interfaces 171 3.7.3 Acquisition Hardware Requirements 174 3.7.4 Firmware Requirements 176 3.7.5 Software Application Requirements 177 3.7.6 Concept of Execution among Subsystems 178 3.8 Gamma Cardio CG Technical File Structure 179 References 180 4 Signal Processing and Estimation 181 Chapter Organization 181 Part I: Theory 184 4.1 Discrete Representations of Analog Systems 184 4.2 Discrete Fourier Transform 189 4.2.1 Discrete Fourier Transform Statistics 194 4.3 Estimation Theory Framework 197 4.3.1 Minimum Mean Square Error Estimate 199 4.3.2 Minimum Mean Absolute Error Estimate (MMAE) 201 4.3.3 Maximum A Posteriori (MAP) Probability Estimate 202 4.3.4 Maximum Likelihood Estimation (MLE) 203 4.4 Performance Indicators 204 4.4.1 Efficient Estimators 208 4.4.2 Fisher’s Information Matrix 209 4.4.3 Akaike Information Criterion 212 Part II: Implementation 214 4.5 Analog to Digital Conversion 214 4.5.1 Indirect Sampling versus Direct Sampling 214 4.5.2 Quantizer Design 216 4.6 Signal Denoising 221 4.6.1 White Gaussian Signals in Additive White Gaussian Noise 221 4.6.2 Denoising of Gaussian Cyclostationary Signals 222 4.6.3 MMSE Digital Filter 222 4.7 Time of Arrival Estimation 224 References 229 5 Applied Electronics 231 Chapter Organization 231 Part I: Theory 233 5.0 Architectural Design 235 5.1 Sensors 236 5.2 Circuit Protection Function 243 5.2.1 Johnson Noise 246 5.2.2 Transient Voltage Suppressors 247 5.2.3 RF Filter Circuit Protection 248 5.2.4 Circuit Frequency Response 251 5.3 Buffer Stage 254 5.3.1 Operational Amplifiers 256 5.4 Analog Signal Processing 258 5.4.1 Summing Amplifier Circuit 259 5.4.2 Analog Signal Switching 260 5.5 Interference and Instrumentation Amplifiers 262 5.5.1 Eliminating In-band Interference 262 5.5.2 Patient Model 267 5.5.3 The ECG Model 268 5.5.4 Right Leg Connection 270 5.5.5 Right Leg Driver Circuit 272 5.6 Analog Filtering 273 5.6.1 Frequency Domain 273 5.6.2 Analog versus Digital Filtering 278 5.7 ADC Conversion 279 5.8 Programable Devices 285 5.9 Power Module 289 5.9.1 Power Sources 290 5.9.2 Electrical Safety and Appliance Design 294 5.9.3 Power Module Design 298 5.10 Baseband Digital Communication 301 5.10.1 Data Transmission Elements 302 Part II: Implementation 313 5.20 Gamma Cardio CG Architecture 313 5.20.1 ECG Design Choices 314 5.20.2 Gamma Cardio CG Complete Scheme 317 5.21 ECG Sensors 317 5.22 Gamma Cardio CG Protection 321 5.23 Gamma Cardio CG Buffer Stage 325 5.24 The Lead Selector 327 5.24.1 Calibration 331 5.25 ECG Amplification 332 5.25.1 ECG Circuits 333 5.25.2 Input Dynamic Range: Requirement Demonstrations 337 5.25.3 Gain Error: Requirement Demonstrations 338 5.26 Analog Filtering 339 5.27 The ADC Circuit 342 5.28 Programable Devices 346 5.28.1 Circuit Design 347 5.28.2 The Clock 348 5.29 Power Module 351 5.29.1 Power Module Circuit 353 5.30 Communication Module 353 Conclusion 357 References 358 6 Medical Software 359 Chapter Organization 359 Part I: Theory 361 6.1 Introduction 361 6.1.1 Intrinsic Risks and Software Engineering 362 6.1.2 Main Concepts in Software Development 363 6.1.3 Regulatory Requirements for Software 364 6.2 The Process: a Standard for Medical Software 365 6.2.1 IEC/EN 62304 Overview 365 6.2.2 Risk Analysis for Hardware and Software Design 368 6.2.3 Software Safety Classification 370 6.2.4 System Decomposition and Risks 371 6.2.5 Impact of Safety Classification 372 6.2.6 Soup 372 6.3 Risk Management Process 374 6.3.1 Risk Management in Software 376 6.3.2 Risk Management for Medical Instrument Software 377 6.4 Software Development Process 379 6.4.1 Software Development Planning 380 6.4.2 Software Requirements Analysis 381 6.4.3 Software Architectural Design 382 6.4.4 Detailed Software Design 385 6.4.5 Software Unit Implementation and Verification 385 6.4.6 Software Integration and Integration Testing 387 6.4.7 Software System Testing 388 6.4.8 Software Release 388 6.5 Software Configuration Management Process 389 6.6 Software Problem Resolution Process 391 6.7 Software Maintenance Process 392 6.8 Guidelines on Software Design 393 6.8.1 Definitions 395 6.8.2 Basic Recommendations 396 6.8.3 Software Core Services 396 6.8.4 Defensive Programing 398 Part II: Implementation 400 6.9 System Decomposition 400 6.9.1 Gamma Cardio CG Use Case 400 6.9.2 System Decomposition 401 6.10 Risk Management 402 6.11 Software Application 403 6.11.1 Software Requirements 403 6.11.2 Architectural Design 407 6.11.3 Elaboration Module 409 6.12 Firmware 411 6.12.1 Firmware Requirements 411 6.12.2 Architectural Design 413 6.12.3 Automatic Test Capability 416 References 418 7 C-health 419 Chapter Organization 420 Part I: Theory 421 7.1 Introduction 421 7.1.1 The Assessment Framework 421 7.1.2 Assessment Framework for the Health Sector 422 7.2 The Cloud Computing Model 426 7.2.1 Basics of Cloud Computing 426 7.2.2 Cloud Platforms 428 7.2.3 Services in the Cloud 430 7.2.4 The Cloud Shape 432 7.2.5 Features of the Clouds 434 7.3 e-Health 435 7.3.1 Interoperability in e-Health 437 7.4 Electronic Health Record (EHR) 442 7.5 c-Health 445 Part II: Implementation 449 7.6 Telecardiology 450 7.6.1 Application Scenario 450 7.7 Telecardiology Technology 451 7.8 Workflow in Telecardiology 455 7.8.1 Basic Workflows 455 7.8.2 Alternative Workflows 457 7.8.3 Where and When Telecardiology Can Be Used 460 7.9 Risks of Telecardiology 463 References 465 8 Certification Process 467 Chapter Organization 467 Part I: Theory 469 8.1 Certification Objectives and Processes 469 8.1.1 Certification, Standards and Definitions 470 8.2 Regulations, Standards and Organizations 474 8.2.1 Technical Standards for Medical Devices 477 8.2.2 European Context 478 8.3 Basic Protection Concepts 480 8.3.1 Protection Against Electric Shock 480 8.3.2 Insulation 484 8.3.3 Degree of Protection Provided by Enclosures 485 8.4 Verification of Constructional Requirements 486 8.4.1 Choice of Safety Critical Materials and Components 486 8.4.2 Creepage Distances and Air Clearances 489 8.4.3 Markings 490 8.4.4 Conductors 492 8.4.5 Connections to the Power Supply 494 8.4.6 Fire Enclosure 495 8.5 Medical Equipment Safety Tests 495 8.5.1 Leakage Current 497 8.5.2 Heating 499 8.5.3 Dielectric Strength 500 8.5.4 Stability and Mechanical Strength 500 8.5.5 Abnormal Operating and Fault Conditions 501 8.5.6 Continuity of Protective Earthing 502 8.5.7 Residual Voltage 503 8.5.8 Voltage on the Accessible Parts 503 8.5.9 Energy Stored – Pressurized Part 503 8.5.10 Current and Power Consumption 504 8.6 Electromagnetic Compatibility 504 8.6.1 Emissions 506 8.6.2 Immunity 511 8.6.3 The Test Report 513 Part II: Implementation 515 8.11 The Process 515 8.11.1 Device Description 516 8.11.2 Medical Device Classes 516 8.11.3 EU Conformity Assessment 519 8.11.4 Risk Management Deliverable 520 8.11.5 The Technical File 527 8.12 Regulatory Approaches to Medical Device Market Placement 537 8.13 Basic Concepts in Device Implementation 540 8.13.1 Protection Against Electric Shock 541 8.13.2 Insulation 541 8.13.3 Enclosure IP Protection 544 8.14 Verification on Design Performance 544 8.14.1 Safety-critical Materials 544 8.14.2 Creepage and Air Clearance 545 8.14.3 Other Verifications 545 8.15 Safety Tests 546 8.15.1 Leakage Current 546 8.15.2 Heating 546 8.15.3 Other Safety Tests 547 8.16 Electromagnetic Compatibility 548 8.16.1 Emission 549 8.16.2 Immunity 550 References 554 Summary of Regulations and Standards 555 Index 559

Read more less

Book SynopsisThe psychiatric profession must ensure that its next generation of leaders has the appropriate skills to provide mental health services in the face of globalization and urbanization, new technologies, and competing demands for shrinking resources.Trade Review“We may agree with the notion that almost every psychiatrist may have the potential and possibility of leading. Let’s hope that those who are, or become, our leaders study this book, learn from it, and do the right things.” (Acad Psychiatry, 31 July 2014)Table of ContentsList of Contributors viii Preface xi Part A The Role of the Leader 1 What is Leadership? 3 Dinesh Bhugra, Susham Gupta and Pedro Ruiz 2 What Makes a Leader? Skills and Competencies 13 Juan J. López-Ibor, Blanca Reneses and María Inés López-Ibor 3 Medical Professionalism, Leadership and Professional Judgement 34 Dinesh Bhugra, Alex Till, Nicholas Deakin and Pedro Ruiz 4 Leadership Theories and Approaches 49 John P. Baker 5 Clinical Leadership 63 Ahmed Okasha 6 Leadership and Clinician Engagement in Service Development 74 Hugo de Waal Part B Skills Required for Leadership 7 Communication 89 Levent Küey 8 Leadership and Decision-Making 99 Dinesh Bhugra, Alex Till and Pedro Ruiz 9 Team-Building in Psychiatry 107 Wolfgang Gaebel, Andreas Kuchenbecker, Noemi Wulff and Jürgen Zielasek 10 Coaching and Mentoring 126 Rebecca Viney and Denise Harris 11 Leadership and Factions 137 Zoë K. Reed 12 Leadership Outside the Clinical Team 147 Juan J. López-Ibor, María Inés López-Ibor and Blanca Reneses 13 Leadership in Academic Psychiatry 163 Dilip V. Jeste and Maja Gawronska 14 Taking People With You 179 David M. Ndetei and Patrick Gatonga 15 Leaders and Managers: A Case Study in Organizational Transformation – the Sheppard Pratt Experience, 1990–2011 189 Robert Roca and Steven S. Sharfstein 16 Burnout and Disillusionment 199 Wulf Rössler 17 Gender Issues Related to Medical Leadership with Particular Reference to Psychiatry 206 Marianne Kastrup and Klement Dymi 18 Leadership for Good versus Good Leadership in Mental Health 217 Sidney H. Weissman and Kenneth G. Busch 19 Acquiring Leadership Skills: Description of an International Programme for Early Career Psychiatrists 226 Norman Sartorius 20 Leadership, Ethics and Managing Diversity 233 Julio Torales, Hugo Rodriguez and Dinesh Bhugra Part c Learning Materials 21 Assessment Tools 241 Cindy L. Ehresman 22 Learning Materials 253 John P. Baker 23 Conclusions 260 Dinesh Bhugra, Susham Gupta and Pedro Ruiz Index 263

Read more less

Book SynopsisHow do our patients come to be the way they are? What forces shape their conscious and unconscious thoughts and feelings? How can we use this information to best help them? This book offers students and practitioners from all fields of mental health a clear, practical, operationalized method for constructing psychodynamic formulations.Trade Review“This informative, thoughtfully organized, Cleary written book addresses a central topic that is being ever more exiled into the shadows of psychiatric knowledge and practice.” (Journal of Clinical Psychiatry, 1 December 2014) "This is the best book I have read on psychodynamic formulation. Clearly written, with a warm, conversational style and numerous clinical examples, this book shows the reader how centrally important a psychodynamic formulation is to understanding the patient and guiding the treatment—not just in psychotherapy—but in all clinical settings. The authors systematically guide the reader in developing skills and building knowledge to construct a psychodynamic formulation and thinking deeply about patients. It is the most comprehensive and accessible learning guide on psychodynamic formulation to date!" (Debra Katz,Vice Chair for Education at the University of Kentucky and Director of Psychiatry Residency Training, USA) “This highly anticipated companion text to Psychodynamic Psychotherapy: A Clinical Manual provides a sophisticated yet easily understandable approach to developing psychodynamic formulations, one of the most challenging and important aspects of learning psychodynamic psychotherapy. Cabaniss and her coauthors understand how to present the complex world of psychodynamic psychotherapy and formulation in a way that beginning students can grasp and apply to their clinical work with patients. The system of developing formulations (Describe-Review-Link) provides focus, clarity and the flexibility to create meaningful ways of understanding our patients that will be of great benefit to both beginners and skilled clinicians. This book is a great advance in the way to approach developing the formulations that are the bedrock of well conceived treatment.” (David A. Goldberg, M.D California Pacific Medical Center, San Francisco, USA)Table of ContentsAcknowledgments ix Introduction xi PART ONE Introduction to the Psychodynamic Formulation 1 1 What is a Psychodynamic Formulation? 3 2 How do We Use Psychodynamic Formulations? 8 3 How do We Construct a Psychodynamic Formulation? 12 PART TWO DESCRIBE 17 4 Self 23 5 Relationships 32 6 Adapting 41 7 Cognition 52 8 Work and Play 61 Putting it Together – A Description of Problems and Patterns 69 PART THREE REVIEW 75 9 What We’re Born with – Genetics and Prenatal Development 81 10 The Earliest Years 90 11 Middle Childhood 101 12 Later Childhood, Adolescence, and Adulthood 113 Putting it Together – A Developmental History 123 PART FOUR LINK 135 13 Trauma 143 14 Early Cognitive and Emotional Difficulties 152 15 Conflict and Defense 163 16 Relationships with Others 173 17 The Development of the Self 182 18 Attachment 191 Putting it Together–A Psychodynamic Formulation 201 PART FIVE Psychodynamic Formulations in Clinical Practice 213 19 Psychodynamic Formulations in Acute Care Settings 215 20 Psychodynamic Formulation in Pharmacologic Treatment 222 21 Psychodynamic Formulation in Long-Term Psychodynamic Psychotherapy: Revising Over Time 230 22 Sharing Formulations with Our Patients 238 Epilogue 247 Appendix – How to Use Psychodynamic Formulation: A Guide for Educators 249 Recommended Reading 253 Index 259

Read more less

Book SynopsisPharmacovigilance Medical Writing covers the preparation of pharmacovigilance documents for all stages of the drug development process (i.e. from clinical development through to applications for marketing authorisations to the post-marketing stage).Trade Review“This book is well structured and should prove useful for pharmacovigilance scientists and writers to have a reference text and checklist for regulatory pharmacovigilance documentation requirements.” (Pharmaceutical Journal, 9 February 2013)Table of ContentsPreface – Pharmacovigilance Medical Writing Comes of Age ix Acknowledgements xiii Abbreviations xv 1 Pharmacovigilance Medical Writing – An Overview Across the Drug Development Process 1 2 Pharmacovigilance Medical Writing for Clinical Trials 5 2.1 Introduction 5 2.2 The EU Annual Safety Report and US IND Annual Report – A Historical Look at Reporting from Clinical Studies 6 2.3 The Development Safety Update Report 9 2.4 References 30 3 Pharmacovigilance Medical Writing for Marketing Authorization 33 3.1 Introduction 33 3.2 The Summary of Clinical Safety 34 3.3 The Integrated Summary of Safety 60 3.4 The 120-Day Safety Update Report 73 3.5 References 74 4 Pharmacovigilance Medical Writing in Risk Evaluation and Management 75 4.1 Introduction 75 4.2 The EU Risk Management Plan 76 4.3 The Risk Evaluation and Mitigation Strategies Report 96 4.4 The Benefit-Risk Evaluation Report 106 4.5 References 114 5 Pharmacovigilance Medical Writing for Marketed Products 117 5.1 Introduction 117 5.2 The EU Periodic Safety Update Report 119 5.3 The US Periodic Adverse Drug Experience Report 147 5.4 The PSUR Addendum Report 157 5.5 The Summary Bridging Report 163 5.6 References 169 6 The Ad-Hoc Safety Review and Response to Questions Document 171 6.1 Introduction 171 6.2 The Ad-Hoc Safety Review 172 6.3 The Response to Questions Document 179 7 The Rest of the World 185 7.1 Introduction 185 7.2 Japan 186 7.3 Canada 188 7.4 Australia and New Zealand 188 7.5 India 189 7.6 Singapore and Taiwan 190 7.7 References 191 Appendices Appendix 1: Sample Line Listing 193 Appendix 2: Sample Summary Tabulation 197 Appendix 3: Another Look at the US IND Annual Report 199 Appendix 4: The New Pharmacovigilance Legislation in the EU 211 Appendix 5: The New EU Risk Management Plan 215 Appendix 6: The New EU Periodic Safety Update Report/Periodic Benefit-Risk Evaluation Report 227 Glossary 253 Index 259

Read more less

Book SynopsisDialectical Behavior Therapy (DBT) has quickly become a treatment of choice for individuals with borderline personality disorder and other complicated psychiatric conditions. Becoming proficient in standard DBT requires intensive training and extensive supervised experience.Trade Review“As the authors state at the outset, it is likely most useful for clinicians wondering what DBT is and what it includes, as well as for non-clinicians wondering what DBT is about. Some of the concepts are good therapy (e.g., the emphasis on validation), whereas some are unique to DBT (e.g., the consult team). Because some of the elements of DBT are good practice and can be incorporated into other treatment modalities, the authors succeed in finding a middle path between ignorance of DBT and trained practice of allelements.” (British Journal of Psychology, 6 January 2014)Table of ContentsAbout the Authors ix Foreword xi Acknowledgments xiii 1 Introduction 3 Part I Theoretical, research, and clinical foundations 13 2 When DBT is indicated: The patients, the clinicians, and the evidence 15 3 BPD: Treatable or untreatable? 27 4 BPD: Diagnosis, stigma, and phenomenology 33 5 Understanding and treating self-harm behaviors in BPD 45 6 The ABC’s of DBT – the theoretical perspective 63 7 The ABC’s of DBT – overview of the treatment 75 Part II Using DBT in clinical practice 83 8 Commitment and goal setting 85 9 The DBT tool kit: The essential DBT strategies and what happens in the individual session 101 10 Skills training: The rationale and structure 125 11 Skills training: The four skill modules 135 12 Between-session contact and observing limits 153 13 Management of suicidal behavior 177 14 The Safety Planning Intervention 185 15 The three C’s of consultation 193 16 DBT case formulation 205 17 Beyond Target 1 – Therapy and “quality of life” interfering behaviors 221 18 The end of treatment 239 Index 245

Read more less

Book SynopsisThe American Board of Psychiatry and Neurology and the Accrediting Council on Graduate Medical Education identify interviewing skills as a core competency for psychiatric residents. This title offers an approach to this topic that fulfills the need for training in biopsychosocial assessment and diagnosis.Trade Review“This book is not only a first rate introduction for psychiatric residents and medical students interested in psychiatry but arguably should be a mandatory reading for all medical students given the importance of general interviewing skills, the prominence of psychiatric issues throughout medicine, and the importance of the techniques presented for building the foundations of the physician-patient relationship.” (Journal of Nervous and Mental Disease, 1 December 2014)Table of ContentsContributors ix Preface xi Acknowledgments xiii Chapter 1 Listening to the Patient 1 Listening: The Key Skill in Psychiatry 1 The Primary Tools: Words, Analogies, Metaphors, Similes, and Symbols 3 How Does One Hear Words in This Way? 4 Listening as More Than Hearing 6 Common Blocks to Effective Listening 7 Crucial Attitudes That Enable Effective Listening 10 Theoretical Perspectives on Listening 14 Using Oneself in Listening 16 To Be Found: The Psychological Product of Being Heard 18 Listening to Oneself to Listen Better 20 Listening in Special Clinical Situations 23 Growing and Maturing as a Listener 26 Chapter 2 Physician–Patient Relationship 31 Formation of the Physician–Patient Relationship 34 Special Issues in the Physician–Patient Relationship 42 The Physician–Patient Relationship in Specific Populations of Patients 44 Conclusion 46 Chapter 3 The Cultural Context of Clinical Assessment 47 Introduction: The Cultural Matrix of Psychiatry 47 What Is Culture? 48 Culture and Gender 50 The Cultural Formulation 51 Ethnocultural Identity 52 Illness Explanations and Help-Seeking 53 Psychosocial Environment and Levels of Functioning 55 Clinician–Patient Relationship 56 Overall Assessment 57 Cultural Competence 57 Working with Interpreters and Culture-Brokers 60 Conclusion: The Limits of Culture 62 Chapter 4 The Psychiatric Interview: Settings and Techniques 65 Goals of the Psychiatric Interview 66 The Psychiatric Database 75 Database Components 77 Mental Status Examination 81 Conduct of the Interview: Factors That Affect the Interview 83 General Features of Psychiatric Interviews 85 Chapter 5 Psychiatric Interviews: Special Populations 103 Randon Welton and Jerald Kay Psychiatric Interview in Special Circumstances 104 Psychiatric Interview in Special Patient Populations 115 Conclusions 131 Chapter 6 Formulation 135 Allison Cowan, Randon Welton and Jerald Kay Biological Contributions 136 Social Factors 138 Psychological Factors 140 Summary 146 Chapter 7 Clinical Evaluation and Treatment Planning: A Multimodal Approach 147 Psychiatric Interview 147 Identifying Information 149 Chief Complaint 149 History of Present Illness 150 Past Psychiatric History 150 Personal History 150 Family History 151 Medical History 152 Substance Use History 152 Mental Status Examination 153 Physical Examination 157 Neurological Examination 158 Psychological and Neuropsychological Testing 159 Structured Clinical Instruments and Rating Scales 159 Laboratory Assessments 159 Neurophysiologic Assessment 159 Brain Imaging 162 Special Assessment Techniques 163 Assessment of Risk 164 Suicide Risk 164 Differential Diagnosis 167 Initial Treatment Plan 170 Conclusion 171 Chapter 8 Professional Ethics and Boundaries 173 Introduction 173 Ethical Behavior and Its Relationship to the Professional Attitude 174 WPA Guidelines on Euthanasia 176 WPA Guidelines on Torture 177 WPA Guidelines on Sex Selection 177 WPA Guidelines on Organ Transplantation 177 WPA Guidelines on Genetic Research and Counseling in Psychiatric Patients 177 WPA Guidelines on Ethnic Discrimination and Ethnic Cleansing 178 WPA Guidelines on Psychiatrists Addressing the Media 178 The Coherent Treatment Frame and the Role of Therapeutic Boundaries in Effective Psychiatric Treatment 178 Boundary Violations 179 Components of the Coherent Psychiatric Frame 180 Stability 181 Avoiding Dual Relationships 182 Autonomy and Neutrality 183 Coherent and Noncollusive Compensation 183 Confidentiality 184 Anonymity 184 Abstinence 185 Self-respect and Self-protection 186 Summary 187 Index 191

Read more less

Book Synopsis* Covers all child and adolescent psychiatric conditions * Prioritizes most commonly occurring disorders * MCQs on companion website to aid learning * Written by experienced clinicians addressing real world issues, such as trauma, abuse, divorce, foster care and school problems .Table of ContentsList of Contributors ix Preface to Clinical Child Psychiatry, Third Edition xiii Section I The Fundamentals of Child and Adolescent Psychiatric Practice 1 Chapter 1 The Initial Psychiatric Evaluation 3 William M. Klykylo Chapter 2 Psychological Assessment of Children 20 Antoinette S. Cordell Chapter 3 Neurobiological Assessment 46 George Realmuto, Bonnie Klimes-Dougan Chapter 4 Educational Assessment and School Consultation 64 Dorothyann Feldis Chapter 5 Psychiatric Assessment in Medically Ill Children 73 James H. Duffee, William M. Klykylo, David M. Rube Chapter 6 How to Plan and Tailor Treatment: An Overview of Diagnosis and Treatment Planning 90 Brian J. McConville, Sergio V. Delgado Chapter 7 Assessment of Infants and Toddlers 107 Martin J. Drell Chapter 8 Play Therapy 120 Susan C. Mumford Chapter 9 Cognitive Behavioral Therapy 130 Christina C. Clark Section II Common Child and Adolescent Psychiatric Disorders 151 Chapter 10 Attention-Deficit Hyperactivity Disorder 153 David M. Rube, Tejal Kaur Chapter 11 Disruptive Behavior Disorders 175 Jennifer P. Edidin, Niranjan S. Karnik, Scott J. Hunter, Hans Steiner Chapter 12 Child and Adolescent Affective Disorders and their Treatment 189 Rick T. Bowers, Christina G. Weston, Julia Jackson Chapter 13 Anxiety Disorders in Childhood and Adolescence 215 Craig L. Donnelly, Jesse C. Rhoads Chapter 14 Substance Use in Adolescents 243 Jacqueline Countryman Chapter 15 Childhood Trauma 255 Julia Huemer, Sidney Edsall, Niranjan S. Karnik, Hans Steiner Chapter 16 Attachment and its Disorders 274 Jerald Kay Chapter 17 The Eating Disorders 289 Randy A. Sansone, Lori A. Sansone Chapter 18 Elimination Disorders: Enuresis and Encopresis 305 Ryan C. Mast, Andrew B. Smith Chapter 19 Sexual Development and the Treatment of Sexual Disorders in Children and Adolescents 325 James Lock, Jennifer Couturier Section III Developmental Disorders 343 Chapter 20 Learning and Communications Disorders 345 Pamela A. Gulley Chapter 21 The Autistic Spectrum Disorders 353 Russell Tobe, Young Shin Kim, Thomas B. Owley, Bennett L. Leventhal Chapter 22 Intellectual Disability (Mental Retardation) 377 L. Lee Carlisle, Bryan H. King, Arthur Maerlender Chapter 23 Movement Disorders: Tics and Tourette's Disorder 399 Kevin Lam, Barbara J. Coffey Chapter 24 Psychotic Disorders 418 Michael T. Sorter, Daniel A. Vogel Chapter 25 Neuropsychological Assessment and the Neurologically Impaired Child 435 Scott D. Grewe, Keith Owen Yeates Chapter 26 The Somatoform Disorders 458 Patricia I. Ibeziako, David Ray DeMaso Chapter 27 Sleep Disorders 475 Martin B. Scharf, Christine V. Wellborn Section IV Special Problems in Child and Adolescent Psychiatry 493 Chapter 28 Loss: Divorce, Separation, and Bereavement 495 Jamie Snyder Chapter 29 Foster Care and Adoption 508 Jill D. McCarley, Christina G. Weston Chapter 30 Child Psychiatry and the Law 518 Douglas Mossman Index 539

Read more less

Book SynopsisPatients with intellectual disability (ID) can benefit from the full range of mental health services. To ensure that psychiatric assessment, diagnosis and treatment interventions are relevant and effective; individuals with ID should be evaluated and treated within the context of their developmental framework. Behavior should be viewed as a form of communication. Individuals with ID often present with behavioral symptoms complicated by limited expressive language skills and undiagnosed medical conditions. Many training programs do not include focused study of individuals with ID, despite the fact that patients with ID will be seen by virtually every mental health practitioner. In this book, the authors present a framework for competent assessment and treatment of psychiatric disorders in individuals with ID. Psychiatry of Intellectual Disability is a resource guide for psychiatrists, nurse practitioners, and other prescribers treating patients with ID. It is a Trade Review"..the book easily surpasses its goal to serve as a manual for the psychiatric treatment of this population, as the chapters provide a solid overview of the subject matter,including contemporary references. Psychiatry of Intellectual Disability: A Practical Manual will definitely appeal to those who spend the majority of their professional time providing psychiatric care to individuals with intellectual disabilities as well as to those with less frequent contact with this patient group." (Journal of Clinical Psychiatry, 2013) “This is a superb and extremely helpful book on the diagnosis and management of patients with intellectual disability. I wish this book were available when I was in training!.” (Doody's, 12 October 2012) "This is a good source of practical information directed at clinicians in the field. Drs. Gentile and Gillig provide us with a concise well referenced survey of the rapidly developing field of community-based management of complex neurobehavioral and psychiatric conditions." (The NADD Bulletin, 2012)Table of ContentsDedications vii Editor biographies ix List of contributors xi List of abbreviations xiii Foreword xv 1 Overview 1 Allison E. Cowan, MD and Julie P. Gentile, MD 2 Psychiatric Assessment 14 Ann K. Morrison, MD and Paulette Marie Gillig, MD, PhD 3 Medical Assessment 26 Julie P. Gentile, MD and Michelle A. Monro, DO 4 Neurologic Conditions 51 Paulette Marie Gillig, MD, PhD and Richard Sanders, MD 5 Traumatic Brain Injuries and Co-occurring Mental Illness 75 Gretchen N. Foley, MD 6 Interviewing Techniques 90 Julie P. Gentile, MD and Paulette Marie Gillig, MD, PhD 7 Mood Disorders 125 Ann K. Morrison, MD and Christina Weston, MD 8 Anxiety Disorders 146 Kelly M. Blankenship, MD 9 Psychotic Disorders 161 Allison E. Cowan, MD 10 Personality Disorders 191 Julie P. Gentile, MD and Allison E. Cowan, MD 11 Aggression 210 Julie P. Gentile, MD and Paulette Marie Gillig, MD, PhD 12 Psychotropic Medications 250 Christopher T. Manetta, DO and Julie P. Gentile, MD 13 Psychotherapy 278 Carroll S. Jackson, LISW-S and Julie P. Gentile, MD 14 Behavioral Assessment and Interventions 309 Betsey A. Benson, PhD 15 Legal Issues for Treatment Providers and Evaluators 325 Jeannette Cox, JD 16 Syndromes of Intellectual Disability 338 Kelly M. Blankenship, MD and Christina Weston, MD Index 366

Read more less

Book SynopsisImprove your sales performance and avoid burnout with Mental Health, resilience, and stress-management strategies. In Stress Less, Sell More: 220 Strategies to Prevent Sales Burnout and Maximize Mental Performance, celebrated sales leader and founder of the Sales Health Alliance, Jeff Riseley, delivers a practical and impactful handbook that makes it easy for sales teams to perform better and build mental health conversations consistently into their busy selling days. In the book, you'll explore ways to navigate the pressures and stressors faced by every sales professional. Its pages can be read day-by-day or all at once, and a companion website supplements the material found in the book with free articles, , and videos. You'll also discover: How to build an individual Mental Health and stress-management toolkit to improve mental resilience and sales performance. Ways to overcome stressors in sales like lost deals, missed targets and buyers ghoTable of ContentsHow to Use This Book xv January 1 Quota Relief 2 Compounding Health 3 PIP 2.0 4 Sales Sabbaticals 5 Intrinsic Motivation 6 Work Hard, Play Hard 7 Kobe 9 The Problem with Slack 10 Slack Hygiene 11 Eight Rules to Live By 12 Take Your Breaks 13 The Problem with Process 14 VP Sales Enablement 15 Interview Questions 16 LeBron James 17 Daily Vitamins 18 Advice from a Friend 20 Remove Your Blockers 21 Hiring Process Burnout 22 Sharing Bad Habits 23 Endnotes 23 February 25 Listen to Your Body 26 Stop the Hamster Wheels 27 Being Present 28 Sales Role Models 29 Recognition vs Praise 31 Treat Them like Family 32 Who Will Be More Motivated? 33 Two Tennis Balls and a Sock 34 When You’re Not 100% 36 How to End Stigmas 37 The Date Jar 39 Who’s More Responsible? 40 David vs Goliath 41 Rejection Handle 42 Dangerous Expectations 43 You Need a Hobby 44 Do Wellness Initiatives Work? 45 Save Past Experiences 47 Responding to Good News 48 Changing Jobs 49 Endnotes 50 March 51 “Grinding” in Sales 52 Fight Together, Not Alone 53 Motivation Bucket Checklist 54 Meaningful Work in Sales 55 Connecting through Failure 56 The Problem with Rewards 57 Pattern Interrupts 58 Steve Kerr 59 Am I Experiencing Burnout? 60 What Are We Doing? 61 Vulnerability Paradox 62 Revenge Bedtime Procrastination 63 Not Programmed to Exercise 64 Sales Is a Marathon 65 Stoicism and Resilience 66 Burnout and Control 67 “Squeezing” Salespeople 69 Formula 1 70 My Team “Looks” Healthy 71 Mindful Eating 72 Endnotes 72 April 73 Messy Humans 74 Exercise for $25,000? 75 Drinking Culture in Sales 76 Prioritize Mental Health 77 Collaboration in Sales 78 Sales Training Confusion 79 Lark or Owl? 80 Have or Have Not 81 Getting Mental Health Wrong 82 Languishing 83 Emotional Experiences 84 Napping in Sales 85 20 Extra Days 86 Don’t Be a Homer 87 Take a Mental Health Day 88 Control What You Can Control 89 Get Involved 90 Protect Your Players 91 Your To-Do List 92 Proactive Sales Onboarding 93 Endnotes 93 May 95 Say NO More 96 Recovery Metrics 97 Personal Growth 98 Unlimited PTO Is Not Enough 99 Contents ix Climb Down into the Hole 100 Mental Health Cost Calculator 101 Uncle Ben 103 Stop and Check 104 The Wim Hof Method 105 The Power of “Yet” 106 Visualizing Sleep 107 Where Is the Off-Ramp? 108 Toxic Sales Dashboards 109 Sharing Openly 110 Why Are You Angry? 111 Components of Hope 113 Not Feeling Motivated? Read This 114 Impact of Job Security 115 Being Supportive 116 Choosing the Right Type of Meditation 117 Endnotes 117 June 119 Craft, Mind, and Body 120 Who Do You Want to Be? 121 The NFL and Sales 122 It’s Showtime! 123 The Power of Appreciation 124 Grab an Umbrella 125 Corporate Greed 126 Learning a New Skill 127 Be Like Mike 128 What Are You Feeling? 129 Endnotes 129 July 131 Back from Vacation 132 Your Signature Move 133 Empowering Sales Teams 135 Top-Down, Bottom-Up 136 Eustress vs Distress 138 Benefits of Meditation 139 Emotional Literacy 140 Compound Resilience 141 Block the Sales Dashboard 143 Upper Limit Happiness 144 The Right Action 145 Hearing vs Listening 146 Distanced from Work 147 Competing Perspectives in Sales 148 Top Performers 149 The Bus Stop 150 Overtraining 151 Afternoon Coffee 152 Email Apnea 153 Theory X or Theory Y 154 Endnotes 154 August 155 Uncoupling from Fear 156 Courageous Vulnerability 157 Mindset Matters 158 Praising Effort and Learning 159 Perception and Targets 160 Becoming a CEO 161 ABCs of Anxiety 162 Sales and Masks 163 Five Dysfunctions of Mental Health 164 Your Voice Matters 165 Mindset and Algorithms 166 The Anxiety Cure 167 Action Thinking 168 Interview Candidates 169 Dark Horses 170 Wellness Day Problems 171 Social Impact 172 Get in Touch 173 Delivering Bad News 175 Stop Making Excuses 176 Endnotes 176 September 177 Stop Wasting Time 178 Suicide Prevention 179 Push-Ups and Sales Burnout 180 Sales Biases 181 Types of Sales Stressors 182 Swing Votes 183 Fear of Loss 184 Doing the Dishes 185 Control Your Information 186 Bad Outcomes of Success 187 The Pre-call Ritual 188 Needs vs Wants 189 Sales Needs Emotion 190 Drinking on the Job 191 Playing the Long Game 193 No One Is Wearing Shoes! 194 High Strain Activities 195 Stop Aiming for Perfect 196 Intermittent Fasting 197 Input-Focused Mindset 198 Endnotes 199 October 201 You Don’t Need Years of Experience 202 Starting the Conversation 203 No Brakes 204 What Is Empathy Really? 205 30 Days of Sweat 206 Ryan Reynolds 207 RATT 208 Working for Workers Act 209 Stop Comparing 210 Your “Spidey-Sense” 211 More Sleep = More Sales 212 “I’m a Failure” 213 Seasonal Changes 214 Maybe They 215 Trust Recession 217 HALT 218 Be Kind to Each Other 219 Did I Matter? 220 Fix Yourself First 221 Hope in Sales 222 Endnotes 222 November 223 Buyer Mental Health 224 Mastery Manipulation 225 Super Mario 226 Failure in Sales 228 “Feeling Lucky” 229 The Drivers 230 Seeds of Growth 231 Planning to Miss 232 Story Editing 233 Instant Gratification 234 Don’t Speak Up 235 Rehearsal Loop 236 Small Actions Matter Most 237 Buyer Ghosting 239 Challenging Experiences 240 The PIP 241 Becoming a Chameleon 242 The First Call 243 Jeff Goldblum 244 The Off-Season 245 Endnotes 245 December 247 Your Inner Citadel 248 Building Empathy 249 Law of the Lever 250 Bad Is Stronger than Good 252 Keeping It Objective 253 Finding the Present 254 How Supported Do You Feel? 255 Naïve Realism 256 Stress-Enhancing Mindset 257 Sleep Best Practices 259 Endnotes 260 Afterword: Salience Bias 261 About the Author 263 Index 265

Read more less

Book Synopsis* Index of trauma and pathological conditions for quick reference * Appendix on measuring performance * Helpful references and suggestions for further reading * Self-assessment tools to support continued learning and development of report writing skills .Trade Review"Having spent nearly 100 years preventing non-medical staff from reporting radiographs, a significant part of the radiological profession, facing with the spiralling radiological workload, is beginning to think otherwise. This book provides an invaluable companion for those who would come around to this 'new' concept. This text is a valuable source of information for the following professional groups. Radiographers experienced in skeletal reporting or undertaking 'red dot' reporting and those training for these roles; medical practitioners, in particular casualty residents who work in emergency departments; physiotherapists and other professional groups who have an interest in musculo-skeletal trauma and pathology. Finally, I would recommend that this book be available on the shelves of imaging departments' libraries for it will greatly help the specialist registrars in radiology. Section one would be particularly read with benefit by the latter." Paediatric Radiology, 2006Table of Contents1. Introduction. Section 1. 2. A Radiologist's Perspective. 3. Legal Aspects Arising in the Reporting of X-rays. 4. Uncertainty and Bias in Decision Making. 5. Pattern Recognition. 6. Anatomy, Physiology and Pathology of the Skeletal System. Section 2. 7. Skeletal Trauma of the Upper Limb. 8. Skeletal Trauma of the Lower Limb. 9. The Spine. 10. Pelvic Fractures. 11. Chest Trauma. 12. The Skull and Face. Appendices. Index

Read more less

Book SynopsisWritten as a companion text to Dr Hesselson's first book about pacing, Simplified Interpretation of ICD Electrograms focuses on teaching an understanding of the electrogram (EGM) signal for troubleshooting ICD rhythms.Table of ContentsTable of Contents. Preface. Foreword. SECTION I - ICD BASICS. Chapter 1: What Is an ICD?. Chapter 2: ICD System and Cardiac Anatomy. Chapter 3: The Hardware. The ICD Generator. The ICD Leads. The ICD Programmer. Chapter 4: ICD Electronics. Defibrillation Waveforms. Defibrillation Polarity and Shock Configuration. Defibrillation Threshold (DFT). Chapter 5: Sensing. Chapter 6: Detection. Chapter 7: The Tachycardias. Chapter 8: The Therapies. Chapter 9: ICD Pacing. Basic Pacing. Pacing for Congestive Heart Failure. Chapter 10: Unusual ICD Situations and Alternate Applications. SECTION II - CASE STUDIES. Chapter 11: Case Studies - Part A. Chapter 12: Case Studies - Part B. SECTION III: ANSWERS. Answers. Index.

Read more less

Book SynopsisThis second edition of the popular book Evidence-based Sports Medicine builds on the features that made the first edition such a valuable text and provides a completely up-to-date tool for sports medicine physicians, family practitioners and orthopedic surgeons. Updated to take into account new evidence from systematic reviews and controlled trials, Evidence-based Sports Medicine is a unique reference book on the optimum management of sports-related conditions. This second edition: contains sections on acute injury, chronic conditions, and injuries to the upper limb, groin and knee and to the lower leg pays increased attention to the important and emerging area of injury prevention features thoroughly revised methodology sections within each chapter, reflecting changes in technique and application MCQs and essay questions that allow readers to continually assess their knowledge and understanding of the topicsTrade Review"The choice of topics and the immense effort that went into the search for appropriate materials is commendable." (Evidence Based Medicine, April 2009) “This book offers a unique, high quality presentation of current clinical evidence…while placing more emphasis on injury prevention and refining literature search techniques.”(Doodys Reviews) Table of ContentsSection 1: Prevention. 1 Is it possible to prevent sports and recreation injuries? A systematic review of randomized controlled trials, with recommendations for future work. Jennifer M. Hootman. 2 Evidence-based preparticipation physical examination. Peter J. Carek. 3 Does stretching help prevent injuries?. Ian Shrier. 4 What effect do core strength and stability have on injury prevention and recovery?. Bryan Heiderscheit and Marc Sherry. 5 Do foot orthoses prevent injury?. Karl B. Landorf and Anne-Maree Keenan. 6 Who should retire after repeated concussions?. Paul McCrory. 7 What recommendations should be made concerning exercising with a fever and/or acute infection?. Christopher A. McGrew. 8 Should you play sport with a congenital or acquired abnormality of a solid abdominal organ?. Abel Wakai and John M. Ryan. 9 What type of exercise reduces falls in older people?. M. Clare Robertson and A. John Campbell. 10 Is there a role for exercise in the prevention of osteoporotic fractures?. Gladys Onambele-Pearson. Section 2: Acute injury. 11 What is the role of ice in soft-tissue injury management?. Chris Bleakley and Domhnall MacAuley. 12 Compression. Andrew Currie and Matthew W. Cooke. 13 NSAIDs and pain management in sports. Weiya Zhang. Section 3: Chronic conditions. 14 Benefits of regular exercise in the treatment and management of bronchial asthma. Felix S.F. Ram and Joanna Picot. 15 What is the role of exercise in the prevention of back pain?. Joanne Dear and Martin Underwood. 16 How should you treat spondylolysis in the athlete?. Christopher J. Standaert and Stanley A. Herring. Section 4: Injuries to the upper limb. 17 How evidence-based is our examination of the shoulder?. Anastasia M. Fischer and William W. Dexter. 18 How effective are diagnostic tests for the assessment of rotator cuff disease of the shoulder?. Jeremy Lewis and Duncan Tennent. 19 How should you treat an athlete with a first-time dislocation of the shoulder?. Marc R. Safran, Fredrick J. Dorey, and Duncan Hodge. 20 Are corticosteroid injections as effective as physiotherapy for the treatment of a painful shoulder?. Daniëlle van der Windt and Bart Koes. 21 How should you treat tennis elbow? An updated scientific evidence-based approach. Alasdair J.A. Santini, Michael J. Hayton, and Simon P. Frostick. Section 5: Injuries to the groin and knee. 22 How reliable is the physical examination in the diagnosis of sports-related knee injuries?. Anthony Festa, William R. Donaldson, and John C. Richmond. 23 What is the optimal treatment of acute anterior cruciate ligament injury?. Graham Bailie and Ian Corry. 24 What is the most appropriate treatment for patellar tendinopathy?. Jill L. Cook and Karim M. Khan. 25 How do you treat chronic groin pain?. Peter A. Fricker and Greg Lovell. Section 6: Injuries to the lower leg. 26 How evidence-based is our clinical examination of the ankle?. C. Niek van Dijk. 27 Can we prevent ankle sprains?. Roald Bahr. 28 How should you treat a stress fracture?. Kim Bennell and Peter Brukner. 29 What is the best treatment of subcutaneous rupture of the Achilles tendon?. Deiary Kader, David J. Deehan, and Nicola Maffulli. 30 How to manage plantar fasciitis. Gerald Ryan. Multiple-choice question answers. Index

Read more less

Book Synopsis[There has been an] extraordinary shift in how we understand and treat psychosis, none more so than in the arena of Early Intervention (EI) bringing with it new hope for young people with emerging psychosis and their families. From the introduction to the book Centred around the Early Psychosis Declaration (EPD), this book explores the declaration''s five themes through contributions from a sizeable number of mental health practitioners, service-users and carers. It is designed to help those working with people experiencing psychosis at an early stage of illness to develop and implement effective early intervention skills, enabling them to examine and refine their practice. Most importantly, the book is a practical guide to delivering early intervention strategies with a unique focus on recovery. Includes an abundance of case studies to link theory to practice Evidence-based Edited by an team with a wealth of clinical and research Trade Review"It will also be of interest to those wanting to know how to convert a common sense idea into workable public health policy and practice." (Nursing Standard, 23 February 2011)Table of ContentsContributors Editor biographies Foreword 1. Introduction (David Shiers and Jo Smith). Theme 1 Improve access and engagement. 2. Duration of untreated psychosis and pathways to care (Kat Brunet and Max Birchwood). 3. Inpatient provision in early psychosis (Tom Craig and Paddy Power). 4. Developing youth focussed services (Kathryn Pugh and Clare Lamb). 5. Strategies for engagement (Lynda Tait, Diane Ryles and Alexa Sidwell). 6. Early intervention service models (Guy Dodgson and Stephen McGowan). 7. Cognitive behavioural interventions in early intervention services (Elizabeth Newton and Emma Cotes). 8. Culturally diversity in early psychosis (Swaran P. Singh and Satnam Singh Kunar). 9. Antipsychotic medicines and their use in first episode psychosis (Alan Farmer). Theme 2 Raising community awareness. 10. Working with diagnostic uncertainty in first episode psychosis (Alan Farmer). 11. Early detection and treatment opportunities for people with emerging psychosis (Paul French). 12. Primary care liaison for individuals with first episode psychosis (David Shiers and Helen Lester). 13. Raising community awareness for early psychosis (Kate Macdonald and Paul Blackburn). 14. Raising awareness in schools (Rowena Passy, Carly Mays, Graham Carr, Glenn Roberts, John Somers and Jos Dawe). Theme 3 Promoting recovery and ordinary lives. 15. Working with motivational difficulties in first episode psychosis (I. Reid, T. Barker and J. Smith). 16. Early intervention and vocational opportunities (Eric Davis, Richard Burden and Ros). 17. Substance misuse in first episode psychosis (Ian Wilson). 18. Relapse prevention in early psychosis (A. Gumley and C. Park). 19. Trauma and first episode psychosis (M. Bernard, C. Jackson and P. Patterson). 20. Suicide prevention in early psychosis (Paddy Power). 21. Managing delayed recovery in first episode psychosis (Charles Montgomery and Glenn Roberts). 22. Nurturing hope in early psychosis: A conceptual model to guide intervention (Dan Pearson). Theme 4 Family engagement and support. 23. Family interventions for first episode psychosis (Frank R. Burbach, Grainne Fadden and Jo Smith). 24. Sharing care with families (Mandy Reed, Sharon Peters and Lizzie Banks). 25. The needs of siblings in first episode psychosis (Jo Smith, Gráinne Fadden and Lucie Taylor). 26. Group based interventions (David Glentworth and Mandy Reed). Theme 5 Practitioner learning. 27. Roles of different professionals (Iain Wright). 28. Shared capabilities in mental health practice (Gina Smith and Sarah J Boldison). 29. Training clinicians working in early intervention (Eric Davis, Mark Rayne, Ian Wilson and Lindsay Rigby). 30. Clinical supervision in early intervention teams (T. Gillam). 31. Conclusion: Where next for early intervention. Index.

Read more less

Book SynopsisThe Nuts and Bolts of Cardiac Resynchronization Therapy By Tom Kenny, RN Vice President, Clinical Education and Training, St.Trade Review“Written by an acknowledged authority in this field, the book meets its goal of serving as a reference for cardiac resynchronization therapy.” Doodys ReviewsTable of ContentsPreface. 1 Understanding Heart Failure. 2 Cardiovascular Anatomy of the Healthy Heart. 3 Cardiac Physiology and Heart Failure. 4 Causes of Heart Failure. 5 The Neurohormonal Model of Heart Failure. 6 An Overview of Heart Failure Drugs. 7 Ventricular Dyssynchrony. 8 Arrhythmias in Heart Failure Patients. 9 Indications for CRT. 10 Types of CRT Systems. 11 Implant Procedures. 12 Basic Programming. 13 Advanced Programming. 14 Basic ECG Interpretation for CRT Systems. 15 CRT System Optimization. 16 Troubleshooting the Non-Responder. 17 Defibrillation Basics. 18 Advanced Defibrillation Functions. 19 Advanced CRT ECG Analysis. 20 DFT Management in CRT-D Patients. 21 Atrial Fibrillation. 22 CRT in Post-AV Nodal Ablation Patients. 23 Special CRT Device Features. 24 Diagnostics. 25 A Systematic Guide to CRT Follow-Up. 26 Troubleshooting. Glossary. Index

Read more less

Book SynopsisRehearse for life in clinical practice with this easy-to-use and unique series, which combines cases drawn from real-life experiences with a refreshing approach to presentations as you would see them in day-to-day situations.Trade Review?This book serves its purpose well. It is an ideal way to shift the learning process from rote memorization to a learner-centered process. The case-based discussions make psychiatric disorders come alive, placing students in the role of medical detective.? (Doody?s Reviews)Table of ContentsIntroduction. How to use this book. Part 1 Basics. Approach to the patient. Mental health treatments. Part 2 Cases. Case 1 A 20-year-old student who collapses in the supermarket. Case 2 A 47-year-old woman who lives in fear that God will punish her. Case 3 An 18-year-old college drop-out gets an eviction order from his parents. Case 4 An 18-year-old trainee chef who cannot go to work. Case 5 Sudden deterioration of a 78-year-old woman in a nursing home. Case 6 A 72-year-old woman with antisocial behaviour. Case 7 A 64-year-old retired teacher's depression is getting worse. Case 8 A 17-year-old man has been cutting his arms. Case 9 A 9-year-old disruptive child faces expulsion from school. Case 10 A 48-year-old security guard with new symptoms every day. Case 11 A 28-year-old man has been arrested at the airport. Case 12 A 24-year-old new mother in distress. Case 13 A 15-year-old head prefect with pneumonia is behaving secretly. Case 14 Insomnia in a 26-year-old successful City man. Case 15 A 15-year-old child assaults his foster mother. Case 16 A 42-year-old woman insists she is pregnant. Case 17 The wife of a 66-year-old GP with Parkinson’s disease is worried about him. Case 18 Complete loss of memory in a fi t middle-aged man. Case 19 A 32-year-old woman puts her GP under pressure. Case 20 The 21-year-old critical medical student. Case 21 A 24-year-old legal secretary with depressed mood and suicidal thoughts. Case 22 A 41-year-old woman with epilepsy develops a different pattern of fits. Part 3 Self-assessment. MCQs. EMQs. SAQs. Answers. Index of cases by diagnosis. Index.

Read more less

Book SynopsisNothing is more perplexing to the clinician new to device therapy than having to deal with cardiac electrocardiograms from a device patient. Pacemakers and other implantable cardiac rhythm management devices leave their imprint on ECGs and can significantly change what clinicians see - or expect to see.Trade Review?This is a concise, well-written introduction to the interpretation of paced rhythms with many well-done recreated practice ECGs that both educate and challenge readers.? (Doody?s Reviews , October 2009)Table of ContentsPreface. Before We Start …. Part I Timing Cycles and Troubleshooting Review. 1 Calculating Rates and Intervals. 2 Pacing Spikes. 3 The Basics of Capture and Sensing. 4 In Depth: Modes. 5 Ventricular Sensing. 6 Pacing Intervals. 7 Loss of Capture. 8 Oversensing. 9 In Depth: Sensing. 10 QRS Morphologies. 11 Fusion and Pseudofusion. 12 In Depth: Single-Chamber Timing Cycles. 13 Intermittent Oversensing. 14 Undersensing. 15 Hysteresis Intervals. 16 In Depth: Hysteresis. 17 Rate Response. 18 Annotated ECGs. 19 AV Synchrony. 20 Atrial Tracking. 21 AV Conduction. 22 States of Dual-Chamber Pacing. 23 Maximum Tracking Rate. 24 Pacemaker Multiblock. 25 Pacemaker Wenckebach. 26 Pacemaker-Mediated Tachycardia. 27 Mode Switching. 28 In Depth: Upper-Rate Behavior in Dual-Chamber Pacemakers. 29 Troubleshooting the Paced ECG. 30 More Troubleshooting the Paced ECG. 31 Automatic Capture Algorithms. 32 Capture Testing. 33 In Depth: Basic Troubleshooting Guide. 34 Navigating the Intracardiac Electrogram. 35 Tracings from a Programmer (Combining E-grams with the ECG). 36 Stored Electrograms. 37 In Depth: Electrograms. 38 Conclusion. Part II Workbook. Introduction to Workbook. Easy. Moderate. Tough. Scramble. Index.

Read more less

Book SynopsisThe Science of Occupational Health is an evidence-based resource for all members of the health care team working with those affected by work-based stress - whether individuals suffering physical or psychological symptoms, or organizations trying to provide optimum conditions for healthy and productive employees. The authors offer a unique psychobiological perspective, discussing the modern workplace as a cause of stimulation and well-being, as well as of distress and illness. They provide a rigorous but highly accessible scientific account of the effects that stress has on mind and body, with key chapters on ''Responses to Stress'', ''Stress-Related Health Problems'', and ''Stress Hormones at Work''. This book offers the reader practical guidance on health promotion and preventive strategies at both individual and organizational levels. It concludes with a discussion of present occupational conditions around the world, and predictions of likely trends in the future.Trade Review"This book offers me additional avenues of study, and I can envision integrating parts of these authors' work into my coaching practice." (Doody's, 4 November 2011) Table of ContentsPreface Foreword Sir Michael Marmot, UCL Acknowledgements 1 Introduction: History of Work and Health General background and aim Work and health from an evolutionary perspective About this book 2 The New Workplace in a Rapidly Changing World Global economy and global competition Flexible organisations – flexible workers Health consequences of ‘sickness presenteeism’ Rationalisation Sources of stress at work 3 The New World of Work Lean manufacturing and just-in-time production Frequent restructuring Lifelong learning, work and family-life balance Long working hours and overtime The role of modern communication technology and telecommuting: work without boundaries, or endless work Diffuse distinction between work and other parts of life The challenge for health and well-being in organisations in the future A flexible workforce 4 Work as a Source of Stimulation and Health or a Cause of Distress and Illness Work-related stress models Justice Positive and negative work Job satisfaction Workaholism Type A behaviour Job strain and heart disorder Conclusion 5 Responses to Stress Mind–body interaction The neuroendocrine stress systems The cardiovascular system Coping with stress Acute stress Chronic stress Short-term versus long-term stress Importance of sleep Allostatic load Catabolic and anabolic processes 6 Stress-related Health Problems Chronic fatigue, depression, burnout Cardiovascular disorders Immune function Cognitive function Obesity, diabetes – the metabolic syndrome Musculoskeletal disorders Ulcers HIV, AIDS and cancer When should I be worried? How can any treatment be efficient? 7 Stress Hormones at Work 8 Socioeconomic Status and Health 9 Health Promotion Health intervention, stress reduction Managing stress in a changing workforce Individual interventions Healthy work Mental capital and well-being Interventions and policies Physically risky jobs Positive psychology Restorative environments and recreation Sleep Physical activity 10 Gender Differences Symptoms, health and life expectancy Work tasks Unpaid work and total workload Children, women and stress 11 Preventive Strategies Occupational hazards Health promotion Occupational conditions in Europe Healthy work SES and health Work–life balance What can we do to reduce stress? Comments on preventive strategies 12 The Future Workplace from a Stress–Health Perspective A changing world Work and health Stress, well-being and productivity Demographic changes in Europe and Japan Global issues References Index

Read more less

Book SynopsisAn insider's look at the medical marijuana debate

Read more less

Book SynopsisThe genetic dissection of human primary immunodeficiency is expanding at full speed, in at least two directions. Some investigators pursue the dissection of well-known clinical phenotypes, for which the count of genetic etiologies seems to be endless, whereas others begin the search for inborn errors underlying new phenotypes, infectious and otherwise. The field of primary immunodeficiency is also expanding in other ways, with new therapeutic approaches, and with the care of patients in regions of the world where these diseases were unheard of less than a decade ago. The volume provides an overview of the field of medical genetics and its progress in 2011. This volume focuses on new developments in “primary immunodeficiencies" (PIDs), insights into PID pathophysiology, and PIDs in India and the Middle East.Volume I opens with a dialog between the volume editors on the definition of PIDs; additional papers in this volume focus on PIDs in Latin America, Eastern and Central Europe, North Africa, Turkey, Asia, Iran, and the South Pacific. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit http://ordering.onlinelibrary.wiley.com/subs.asp?ref=1749-6632&doi=10.1111/(ISSN)1749-6632. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.

Read more less

Book SynopsisThe volume features current basic, clinical, and translational research on aspects of skeletal morphogenesis and remodeling in health and disease. Papers survey vital new insights into the mechanisms of bone development and restructuring, including cellular and mechanical triggers, receptors and signaling pathways. Also covered are the effects of other physiological systems and disease states, such as immune system inflammation, diabetes, infection, and cancer on musculoskeletal health. Recent findings are shaping therapeutic directions that focus on both anti-resorptive and anabolic therapies. Basic scientists, clinical investigators, and clinicians with interests spanning endocrinology, physiology, cell biology, pathology, genetics, molecular biology, rheumatology, oncology, and other areas that relate to bone development and homeostasis will find this a valuable resource for the most recent developments in skeletal biology and medicine. This volume presents manuscripts stemming from the 4th New York Skeletal Biology and Medicine Conference, held at Mount Sinai School of Medicine in New York City on April 27–30, 2011. The papers included in this volume include two of the topic areas presented at the conference; the other topic areas are included in Skeletal Biology and Medicine I. NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit http://ordering.onlinelibrary.wiley.com/subs.asp?ref=1749-6632&doi=10.1111/(ISSN)1749-6632. ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.

Read more less

Book SynopsisThis Annals volume includes invited short reviews on topics presented at the 7th International Cancer Vaccine Symposium “Renaissance of Cancer Immunotherapy”, held September 9-11, 2012 in Florence, Italy. The papers cover the latest progress in basic immunology research and its translation to cancer patients. The meeting and papers pay tribute to the successes in the last few years that have led to the approval of new immunotherapies and the awarding of the Nobel Prize in medicine to three immunologists. The symposium is dedicated to one of these recipients, Dr. Ralph Steinman who discovered dendritic cells, immune cells that are vital in immune responses and immunotherapies for cancer. NOTE: Annals volumes are available for sale as individual books or as a journal. For more information on institutional journal subscriptions, please visit: http://ordering.onlinelibrary.wiley.com/subs.asp?ref=1749-6632&doi=10.111/(ISSN)1749-6632 ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information on becoming a member.Table of ContentsIntroduction to The Renaissance of Cancer Immunotherapy vOlivera J. Finn and Gerold Schuler Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy 1Matthews D. Vesely and Robert D. Schreiber Cell-extrinsic effects of the tumor unfolded protein response on myeloid cells and T cells 6Maurizio Zanetti Immunotherapy in preneoplastic disease: targeting early procarcinogenic inflammatory changes that lead to immune suppression and tumor tolerance 12Bridget Keenan and Elizabeth M. Jaffee Integration of epidemiology, immunobiology, and translational research for brain tumors 17Hideho Okada, Michael E. Scheurer, Saumendra N. Sarkar, and Melissa L. Bondy Human dendritic cells subsets as targets and vectors for therapy 24Eynav Klechevsky and Jacques Banchereau Dendritic cell immunotherapy 31Rachel Lubong Sabado and Nina BhardwajMolecular programming of steady-state dendritic cells: impact on autoimmunity and tumor immune surveillance 46Dylan J. Johnson and Pamela S. Ohashi Preventing cancer by targeting abnormally expressed self-antigens: MUC1 vaccines for prevention of epithelial adenocarcinomas 52Pamela L. Beatty and Olivera J. Finn Immunological control of cell cycle aberrations for avoidance of oncogenesis: the case of tetraploidy 57Laura Senovilla, Lorenzo Galluzzi, Maria Castedo, and Guido Kroemer Ongoing adaptive immune responses in the microenvironment of melanoma metastases 62Nicolas van Baren and Pierre G. Coulie Main features of human T helper 17 cells 66Francesco Annunziato, Lorenzo Cosmi, Francesco Liotta, Enrico Maggi, and Sergio Romagnani In silico modeling of cancel cell dissemination and metastasis 71Lu-En Wai, Vipin Narang, Alexandre Gouaillard, Lai Guan Ng, and Jean-Pierre Abastado Common pathways to tumor rejection 75Ena Wang, Davide Bedognetti, Sara Tomei, and Francesco M. Marincola Cancer-induced immunosuppressive cascades and their reversal by molecular-targeted therapy 80Yutaka Kawakami, Tomonori Yaguchi, Hidetoshi Sumimoto, Chie Kudo-Saito, Nobuo Tsukamoto. Tomoko Iwata-Kajihara, Shoko Nakamura, Hiroshi Nishio, Ryosuke Satomi, Asuka Kobayashi, Mayuri Tanaka, Jeong Hoon Park, Hajime Kamijuku, Takahiro Tsujikawa, and Naoshi Kawamura

Read more less

Book SynopsisThe current “generalized digitization” of society is influencing the health environment, healthcare organizations as well as actors. In this context, human and social sciences deconstruct, nuance and sometimes even challenge certain preconceived ideas and/or dominant discourses. In this book, researchers of four nationalities and three different disciplines have agreed to open the “black box” of their work. They display their scientific practices from the perspective of epistemology, ethics and methodology. They present and analyze their values and postulates but, also, what may have influenced the project, the definition of the object and objectives, as well as their approaches. In a contextual way, the first part presents some changes in environments and infocommunicational practices related to digital health. The second part opens space to reflect on ethics and deontology. Finally, postulating that scientific fact is not an essence but the result of a process, the last part discusses the methods implemented, which may be different from those initially envisaged. This book is dedicated to the researchers and postgraduate students in the human and social sciences as well as the health practitioners likely to collaborate with them. Table of ContentsForeword xi Introduction xiiiLaurent MORILLON Part 1. Changes in Contexts and Info-communication Practices Related to the Digital Environment in the Health Field 1 Chapter 1. Health and Digital Technology: Reflexive Feedback on Some Works 3Hélène ROMEYER 1.1. Introduction 3 1.2. Voluntary changes over the last 50 years 4 1.2.1. An old but partial political desire 5 1.2.2. Coexistence of two types of information: medical and health information 7 1.3. Significant issues 9 1.3.1. Economic and professional issues 9 1.3.2. A plethora of information 11 1.3.3. Attempts to control 13 1.4. New uses 14 1.4.1. Continued confidence in physicians 15 1.4.2. Beyond information: life stories and testimonies 16 1.5. Conclusion 19 1.6. References 19 Chapter 2. Social and Digital Resources: The Hindered Information Practices of Cancer Patients 23Adrien DEFOSSEZ 2.1. Introduction 23 2.2. Patients and information 24 2.3. Getting information from family and friends when suffering from cancer 26 2.3.1. Which relatives are likely to provide what kind of information? 26 2.3.2. Difficulty in asking people around you for information 28 2.4. Getting information on the Internet when you are sick with cancer 30 2.4.1. Widespread use for limited benefits 30 2.4.2. The health Internet: a misleading exposure 33 2.5. Conclusion 34 2.6. References 35 Chapter 3. Health at the In-between of Computing and the Information and Communication Sciences 39Philippe MARRAST 3.1. Introduction 39 3.2. The hospital, a field to observe 41 3.3. An abductive and iterative approach for an “in-between” positioning 44 3.4. A theoretical diversity to characterize complex organizations 47 3.5. Conclusion 49 3.6. References 50 Chapter 4. Mental Health and Support for Disaster Victims. Info-communication Devices for Training Volunteer First-aid Workers in a Digital Environment 55Silvia Rosa SIGALES RUIZ, Erik DE SOIR, Claudia Veronica MARQUEZ GONZALEZ and Michèle CARIA 4.1. Introduction 55 4.2. Studying manuals to train volunteer rescue workers in psycho-emotional support for disaster victims 56 4.3. Four analysis guides 57 4.3.1. Metadata for online documents 58 4.3.2. Pedagogical engineering of online textbooks 59 4.3.3. Mental health intervention protocols 61 4.3.4. Disaster management protocols 64 4.4. An info-communication device for online training in disaster response 66 4.5. Conclusion 68 4.6. Appendix 69 4.7. References 70 Part 2. Thinking about the Ethics of Health Research in a Digital Context 75 Chapter 5. Ethical Positions Arising from Research on Online Communities in the Health Sector 77Aurélie POURREZ, Elodie CRESPEL, Stéphane DJAHANCHAHI, Olivier GALIBERT and Benoît CORDELIER 5.1. Introduction 77 5.2. Epistemology, deontology and ethical reflection 79 5.2.1. From the necessary scientific reflexivity to empirical and methodological scientific ethics 79 5.2.2. ICS and methodological and empirical ethics related to the study of NICTs 80 5.2.3. Empirical and methodological ethics 82 5.3. Empirical and methodological ethics in ICS and digital health 84 5.3.1. Collecting authorizations and approvals 84 5.3.2. Concealing or revealing oneself as a “researcher-observer”? 85 5.3.3. Protecting respondents 87 5.3.4. Protecting researchers in controversies and emotionally engaging research 88 5.4. Conclusion 89 5.5. References 91 Chapter 6. Action Research at La Poste to Prevent the Psychosocial Risks Associated with Digital Acculturation 93Emilie BLANC 6.1. Introduction 93 6.2. The relevance of action research to prevent psychosocial risks 94 6.3. What method in action research prevents psychosocial risks? 97 6.4. Action research for ethical questions 98 6.5. Conclusion 100 6.6. References 101 Part 3. Thinking Approaches to Health Research in a Digital Context 103 Chapter 7. Interests and Limitations of Interdisciplinary Research in a Living Lab to Meet the Needs of Senior Citizens 105Elizabeth BOUGEOIS and Hélène GERMAIN 7.1. Introduction 105 7.2. Reconsidering a Living Lab study: the centrality of user-experts 108 7.2.1. Senior citizens and new technologies in a controlled environment 109 7.2.2. The second study or how to reconsider research practices 110 7.3. When experts-users tell researchers where to look 112 7.3.1. Use of human, technical and digital aids by respondents 112 7.3.2. Projected uses: from voice command to “smart” robots 114 7.4. Among researchers: postures linked to disciplinary backgrounds 115 7.5. Conclusion 117 7.6. References 119 Chapter 8. For a Comprehensive Approach to the Info-communication Practices of Breast Cancer Prevention Stakeholders: A Reflection on Screening 123Dorsaf OMRANE and Pierre MIGNOT 8.1. Introduction 123 8.2. State of the art of organized screening, a complex prevention system 125 8.2.1. Screening: device, issues and controversies 125 8.2.2. Representation of screening: between confidence and mistrust 128 8.3. Need to understand the field of screening: methodological framework 129 8.3.1. Exploratory approach: quantitative reflection on screening 130 8.3.2. Ethnographic survey and qualitative content analysis: a comprehensive approach to screening 132 8.4. Conclusion 135 8.5. References 136 Chapter 9. Health Research on Immunization after 2016: The Need for a Plural Methodological Approach 141Mylène COSTES and Audrey ARNOULT 9.1. Introduction 141 9.2. An exploratory study that raises methodological questions 143 9.2.1. Construction of research questions 143 9.2.2. A test methodology with limitations 144 9.2.3. Reflexivity on the concept of “axiological neutrality” 145 9.2.4. Unexpected results that lead to (re)thinking the method deployed 145 9.3. The use of lexicometry for the analysis of interviews on vaccine hesitation and opposition 148 9.3.1. Expanded field and themes 148 9.3.2. The potential contributions of the Iramuteq software to health research 150 9.4. Conclusion 152 9.5. References 153 Chapter 10. Qualitative Research in Health, in Sign Language: Multimodality and Interculturality of Analytical Work 159Sophie DALLE-NAZEBI 10.1. Introduction 159 10.2. Topicality of methodological issues in SL research 160 10.2.1. Context and issues in SL health research 160 10.2.2. The communication dimension at the heart of research activities 161 10.3. The communication challenges of interviews in SL 162 10.3.1. Challenges of a fine work on what is said in SL 163 10.3.2. Domesticating the camera, keeping your hand on the format of exchanges 165 10.3.3. Interacting in SL: a repositioning of bodies and objects 166 10.4. Exposing SL speech analysis in publications 167 10.4.1. Sharing benchmarks, a professional vision 167 10.4.2. Test of an example 168 10.4.3. The communicational anchoring of reading 172 10.5. Conclusion 173 10.6. References 174 Postface 177 Laurent MORILLON List of Authors 181 Index 183

Read more less

Book SynopsisReminiscence, life review, life story, autobiography, etc., are popular activities undertaken with or by older adults, whether for personal or therapeutic reasons. The act of reminiscing takes many forms, often very freeform, but this book presents a specific, structured approoach that has been extensively researched and found to provide measurable therapeutic benefits.Haight's Life Review process involves eight one-hour sessions that are organized around Erik Erikson's eight developmental accomplishments, or life stages: trust (early childhood), autonomy and initiative (childhood), industry (early adolescence), identity (adolescence), intimacy (early adulthood), generativity (older adulthood), and integrity (old age). Some people have not achieved one or more of these goals over the course of their lifetimes and the Life Review process offers an opportunity to rethink experiences in a way that helps them achieve these goals through understanding and acceptance of the past. Although this Life Review process has been used effectively with teenagers and other populations, the target audience for this book is older adults, especially those who have had difficult lives, to help them achieve integrity, which is an acceptance of the life lived rather than despair over it.The book describes in detail the role of the interviewer (Therapeutic Listener) and of the Life Reviewer. A chapter is devoted to each session, describing goals and instructions for the session along with sample dialogue from actual listeners - reviewers that illustrate the types of experiences and responses that may be elicited. Much of the text focuses on methods to be used by Listeners to facilitate the reminiscence process, including communication techniques, counseling techniques, assessment techniques, and even how to arrange the physical space to maximize comfort and minimize distractions. Different types of participants are described and effective methods of interviewing them are offered, always with case study examples that demonstrate the techniques.

Read more less

Book SynopsisNano-therapeutics for Colorectal Cancers with Nano-biomaterials.- Nanotherapeutics for Cardiovascular Diseases with Nanobiomaterials.- Nano-therapeutics for multidrug resistance with nanobiomaterial.- Biomedical Applications of Nanomaterials as a diagnostic and therapeutic platform for Diabetes Mellitus.- Nanotherapeutics for Alzheimer's Disease with nano biomaterials.- Metals and non-metals doped carbon dots Synthesis, properties and its applications.- Nanocomposite Biomaterials Merging Nature With Nanotechnology.- Emerging Trends in Nanoparticle Biosynthesis and Their Application as a Novel Biomaterial.- Advancements in Metal Bionanocomposites for Neurodegenerative Diseases.- Recent Enzyme Discovery Engineering Strategies for Biocatalysis and its applications.- Nanomaterial based point of care devices: Medicinal Applications.- Nanotherapeutics for diabetic foot ulcer and wound healing with metal Nano-Bio materials.

Read more less

Book SynopsisPsiconeuroendocrinoinmunología (PNEI) es el resultado de décadas de investigación científica dedicada a la relación mente-cuerpo, basándose en fundamentos sólidos de biología molecular en un enfoque sistémico. La PNEI tiene reconocimiento internacional como un nuevo modelo para conocer el organismo humano en la salud y en la enfermedad. Esta obra da acceso a una materia compleja a través del empleo riguroso del lenguaje científico, evitando los tecnicismos inservibles y facilitando la lectura a los profesionales.

Read more less

Book SynopsisBe Guided by the Evidence. Somatoform disorders are more common than many clinicians realize and are often underdiagnosed and poorly managed. This practical guide provides a comprehensive overview of all somatoform disorders.Trade Review"…an informative and comprehensive new book on a group of common but difficult disorders. The book should be read by all clinicians. I highly recommend it." (Doody's Health Services)Table of ContentsList of Reveiw Contributors. Preface. CHAPTER 1. SOMATIZATION AND CONVERSON DISORDERS. Somatization and Conversion Disorders: A Reveiw (Harold Merskey and Francois Mai). COMMENTARIES. 1.1 From Hysteria to Somatization Francis Creed. 1.2 Somatoform and Conversion Disorders or Somatic Presentations of Mental Disorders (Javier J. Escobar). 1.3 Are Somatoform Disorders a Distinct Category? (Gregory E. Simon). 1.4 Somatoform Disorders: Deconstructing a Diagnosis (Oye Gureje). 1.5 The Psychbiology of Somatization and Conversion Disorders (C. Robert Cloninger and Mehmet Dokucu). 1.6 Patient or Process (Linda Gask). 1.7 Reading the Body (Leslie Swartz). 1.8 Somatization and Conversion Disorders: A Forgotten Public Health Agenda (Shekhar Saxena). 1.9 A Cognitive Account on Conversion and Somatization Disorders (Karin Roelofs). 1.10 Labelling the Unfathomable (Bart Sheehan). 1.11 Somatization and Conversion: An Ongoing Controversy (Carsten Spitzer and Hans Jorgen Grabe). 1.12 The Mind-Body Dualism and Conversion Disorders (Carlo Faravelli and Massimo Lai). 1.13 Concepts of Medically Unexplained Symptoms in Relation to Mind-Body Dualism (Athula Sumathipala). 1.14 A Challenge for Both Clinicians and Researchers (Antonio Lobo). 1.15 Somatization Disorders in the African Context (Frank G. Njenga, Anna N. Nguithi and Rachel Kang'ethe). 1.16 Somatization and Conversion Disorders: An Arab Perspective 9Tarek A. Okasha). 1.17 Much Theory, but Little Agreement (Alberto Perales and Hector Chue). CHAPTER 2. PAIN DISORDER. Pain Disorder: A Reveiw (Steven A. King). COMMENTARIES. 2.1 The Major Paradigm Shift from the Biomedical Reductionist to the Biopsychosocial Approach to the Assessment and Treatment of Pain (Robert J. Gatchel). 2.2 DSM and Pain: When (if ever) is Pain Truely a Psychiatric Disorder? (Robert Boland). 2.3 Pain Disorder or Just Pain: Can We Escape Dualism? (Robert G. Large and Tipu Aamir). 2.4 The Mind-Body Ditchotomy in the Modern World (Hans Jorgen Grabe and Cartsen Spitzer). 2.5 Chronic Pain: Towards a Biopsychosocial Perspective (Michael Bach and Martin Aigner). 2.6 Pain Disorder: Where's the Utility? (Lance M. McCracken). 2.7 Patients must be at the Centre of Pain Management (Joanna M.Zakrzewska). 2.8 Chronic Pain: the Importance of a Comprehensive History (Gerald M. Aronoff). 2.9 Psychological and Physiological Factors in Pain Disorder (Morten Birket-Smith). 2.10 Does the Somatoform Disorder Approach Broaden Our Perspective on Pain? (Wolfgang Hiller and Paul Nilges). 2.11 Diagnosis and Treatment of Pain: Consultation-Liason Psychiatry Aspects (Albert Diefenbache)r. 2.12 Pain: Suffering, Semantics, and Sensitization (Jeffrey Rome). 2.13 Subjectivity and Communitas: Further Considerations on Pain (Etzel Cardena). 2.14 The Relationship Between Pain and Anxiety Disorders (Antonio Bulbena, Carlos Garcia Ribera and Lili Sperry). 2.15 Gaps in Evidence Base of Pain Disorders (Santosh K. Chaturvedi). 2.16 Pain in Genral Practice (Manual Suarez Richards and Gustavo Alfredo Delucchi). CHAPTER 3. HYPOCHONDRIASIS. Hypochondriasis: A Reveiw (Russell Noyes Jr). COMMENTARIES. 3.1 Hypochondriasis: Future Directions in Classification and Etiology Research (Steven Taylor and Gordon J.G. Asmundson). 3.2 Making Sense of Hypochondriasis (Jonathan S. Abramowitz). 3.3 Hypochndriasis: An Endless Source of Controversies (Vladan Starcevic). 3.4 Hypochondriasis: Defining Boundaries, Exploring Risk Factors and Immunology (Eamonn Ferguson). 3.5 Hypochondriasis, Health Anxiety, and Cognitive-Behavoural Therapy (Patricia Furer and John R. Walker). 3.6 Progress with Hypochondriasis (Theo K. Bouman). 3.7 The Clinical Spectrum of Hypochondriacal Fears (Giovanni A. Fava and Stefania Fabbri). 3.8 A Nosological Nightmare (Geoffrey G. Lloyd). 3.9 Hypochondriacal Syndromes: Where Did They Go? (Driss Mousaoui). 3.10 Dimensional Versus Categorical Approach to Obsessions, Delusions, and Hypochondriasis (Joseph Zohar). 3.11 The Nosographic Complexity of Hypochondriasis and the Ambiguilty of the Bpdy (Hector Perez-Rincon). 3.12 Hypochondriasis: Is There a Promising Treatment? (Tewfik K. Daradkeh). CHAPTER 4. BODY DYSMORPHIC DISORDER. Body Dysmorphic Disorder: A Reveiw (Guilio Perugi and Franco Frare). COMMENTARIES. 4.1 The Complexity of Body Dysmorphic Disorder (Vilma Gabbay and Rachel G. Klein). 4.2 Preoccupation with Appearance: Limitations of Our Understanding and Treatment (Jon E. Grant). 4.3 Translational and Evolutional Models of Body Dysmorphic Disorder (Dan J. Stein). 4.4 Our Evolving Understanding of Body Dysmorphic Disorder (Nancy J. Keuthen and Antje Bohne). 4.5 Is Body Dysmorphic Disorder a Culturally Determined Expression of a Body Image Disorder? (David H. Gleaves and Suman Ambwani). 4.6 Body Dysmorphic Disorder: Awareness Needed (Don E. Jeffreys). 4.7 Recent Findings in Body Dysmorphic Disoder and Future Drections (Sabine Wilhelm and Ulrike Buhlmann). 4.8 Body Dysmorphic Disorder: Some Issues Conserning Classification and Treatment (Fugen Neziroglu). 4.9 Body Dysmorphic Disorder: The Antithesis of Narcissus (Andrew A. Nierenberg). 4.10 Playing the Devil's avocate: Is The Concept of Delusional Disorder, Somatic Type, Condemned to Extiction? (Leonardo F. Fontenelle, Mauro V. Mendlowicz and Marcio Versiani). 4.11 Advancing the Understanding of Dysmorphic Disorder (Eric Hollander and Bernardo Dell'Osso). 4.12 Is Body Dysmorphic Disorder More Than a DSM Construct? (Michel Botbol). 4.13 Body Dysmorphic Disorder and Obsessive-Compulsive Disorder: More Simularities than Differences (Euripedes C. Miguel, Albina R. Torres and Ygor A. Ferrao). CHAPTER 5. CHRONIC FATIGUE AND NEURASTHENIA. Chronic Fatigue and Neurasthenia: A Reveiw (Michael C. Sharpe and Simon Wessely). COMMENTARIES. 5.1 From Neurasthenia to Chronic Fatigue Syndrome: A Journey, Not a Destination (Kurt Kroenke). 5.2 Tired People Challenge Medicine (Stefan Priebe). 5.3 Disease, Sickness or Illness: Which One Is Chronic Fatigue Syndrome and / or Neurasthenia? (Bedirhan Ustun). 5.4 Constructing Chronic Fatigue: Empiricism, Pyschiatry, and Sociocultural Contexts (Renee R. Taylor). 5.5 Chronic Fatigue Syndrome as a Paradigm for Pyschosomatic Medicine (James L. Levenson). 5.6 Beyond Fashion (Gordon Parker). 5.7 Chronic Fatigue and Disembodied DSM (Sing Lee and Arthur Kleinman). 5.8 Problems of Definition, Etiological Approaches and Issues of Management in Chronic Fatiguing Disorders (Anne Farmer and Tom Fowler). 5.9 Chronic Fatigue Syndrome: Time to Concentrate on Fatigue, Not Chronicity (Petros Skapinakis and Venetsanos Mavreas). 5.10 Chronic Fatigue Syndrome: A Real Disease, A Real Problem (Jonathan R. Price). 5.11 The Specificity of Chronic Fatigue, Neurasthenia, and Somatoform Disorders (Winfried Reif). 5.12 Chronic Fatigue in Developing Countries (Vikram Patel). 5.13 Functional Somatic Syndromes: Many Names for the Same Thing? (Marco Antonio Brasil, Jose Carlos Appolinario and Sandra Fortes). 5.14 Recent Developments in Chronic Fatigue Syndrome (Ruud C.W. Vermeulen). 5.15 Does Nuerasthenia Really Exist in this Century? (Edmond Chiu). CHAPTER 6. FACTITIOUS PHYSICAL DISORDERS. Factitious Physical Disorders: A Reveiw (Stuart J. Eisendrath and John Q. Young). COMMENTARIES. 6.1 Wilful Deception as Illness Behavour (Christopher Bass). 6.2 Factitious Disorders: Diagnosis or Misbehavour/ (Charles V. Ford). 6.3 Factitious Disorder and Malingering: The Doctors Dilemma (Stephen M. Lawrie and Michael C. Sharpe). 6.4 Factitious Physical Disorders: The Challenges of Efficient Recognition and Effective Intervention (Lois E. Krahn). 6.5 Some Aspects of Factitious Physical Disorders by Proxy (Christopher Cordes). 6.6 Inventing Illness: The Deviant POatient (Don R. Lipsitt). 6.7 Characterizing Factitious Physical Symptoms (David G. Folks). 6.8 Moral Constraints, Regret, and Remorse in Treating Patients with Factitious Disorder (Ovidio A. De Leon). 6.9 Fact, Fiction, Factitious, or Fractious Disorders (Dinesh Bhugra). 6.10 Factitious Physical Disorders: A Strategy of Survival for Medically Trained Traumatized Borderlines? (Ramon Florenzano). 6.11 Factitious Physical Disorders and Malingering: The Hazardous Link (Saida Douki, Sara Benzineb and Fathy Nacef). Index.

Read more less

Book SynopsisThis book provides comprehensive coverage of speech and language disorders arising from pathological processes involving the subcortical structures of the brain. It gives an understanding of these disorders in terms of their neuropathological basis, clinical symptomatology and prognosis.Table of ContentsSECTION A: INTRODUCTION. 1. Subcortical Involvement in Speech and Language: An Introduction and Historical Perspective. 2. Neuroanatomy and Functional Neurology of the Subcortical Region. SECTION B: SUBCORTICAL LANGUAGE DISORDERS. 3. Models of Subcortical Participation in Language. 4. Language Disorders Associated with Striatocapsular and Thalamic Lesions. 5. Pallidal and Thalamic Involvement in Language: Evidence from Stereotactic Surgical Studies. 6. Role of the Subthalamic Nucleus in Language. 7. Influence of the Cerebellum on Language Function. 8. Degenerative Subcortical Syndromes: Aetiology, Clinical Features, Medical Treatment and Associated Language Disorders. 9. Assessment and Treatment of Subcortical Language Disorders. SECTION C: SUBCORTICAL SPEECH DISORDERS. 10. Role of the Subcortical Structures in Speech Motor Control. 11. Dysarthria Associated with Subcortical Pathologies. 12. Subcortical Dysarthrias: Assessment and Treatment.

Read more less

Book SynopsisRecent advances in nanomedicine offer ground-breaking methods for the prevention, diagnosis and treatment of some fatal diseases. Amongst the most promising nanomaterials being developed are magnetic nanomaterials, including magnetic nanoparticles and magnetic nanosensors. Some nanomagnetic medical applications are already commercially available with more set to be released over the coming years. Nanomedicine, Design and Applications of Magnetic Nanomaterials, Nanosensors and Nanosystems presents a comprehensive overview of the biomedical applications of various types of functional magnetic materials. The book provides an introduction to magnetic nanomaterials before systematically discussing the individual materials, their physical and chemical principles, fabrication techniques and biomedical applications. This methodical approach allows this book to be used both as a textbook for beginners to the subject and as a convenient reference for professionals in the field. Table of ContentsCONTENTS Preface About the Authors Introduction 1.1 What is nanoscience and nanotechnology 1.2 Magnets and nanometers: mutual attraction 1.3 Typical magnetic nanomaterials 1.4 Nanomedicine and magnetic nanomedicine 1.5 Typical biomedical applications of functional magnetic nanomaterials Physical background for the biomedical applications of functional magnetic nanomaterials 2.1 Requirements for biomedical applications 2.2 Fundamentals of nanomagnetism 2.3 Magnetic relaxation of ferrofluids 2.4 Magnetorheology of ferrofluids 2.5 Manipulation of magnetic particles in fluids 2.6 Interactions between biological nanomaterials and functionalized magnetic nanoparticles Magnetic nanoparticles 3.1 Introduction 3.2 Basics of nanomagnetics 3.3 Synthesis techniques 3.4 Synthesis of magnetic nanoparticles 3.5 Bio-inspired magnetic nanoparticles 3.6 Functionalization of magnetic nanoparticles 3.7 Future prospects Biomedical applications of magnetic nanoparticles 4.1 Introduction 4.2 Diagnostic applications 4.3 Therapeutic applications 4.4 Physiological aspects 4.5 Toxic effects Magnetosomes and their biomedical applications 5.1 Introduction 5.2 Magnetosome formation 5.3 Cultivation of magnetotactic bacteria 5.4 Characterization of magnetosomes 5.5 Biomedical applications of magnetosomes Magnetic nanowires and their biomedical applications 6.1 Introduction 6.2 Magnetism of magnetic nanowires 6.3 Template-based synthesis of magnetic nanowires 6.4 Characterization of magnetic nanowires 6.5 Functionalization of magnetic nanowires 6.6 Magnetic nanowires in suspension 6.7 Biomedical applications of magnetic nanowires Magnetic nanotubes and their biomedical applications 7.1 Introduction 7.2 Magnetism of nanotubes 7.3 Multifunctionality of magnetic nanotubes 7.4 Synthesis and characterization of magnetic nanotubes 7.5 Biomedical applications of magnetic nanotubes Magnetic biosensors 8.1 Introduction 8.2 Magnetoresistance-based sensors 8.3 Hall effect sensors 8.4 Other sensors detecting stray magnetic fields 8.5 Sensors detecting magnetic relaxations 8.6 Sensors detecting ferrofluid susceptibility Magnetic biochips: basic principles 9.1 Introduction 9.2 Biochips based on giant magnetoresistance sensors 9.3 Biochips based on spin valve sensors 9.4 Biochips based on magnetic tunnel junctions 9.5 Fully integrated biochips Biomedical applications of magnetic biosensors and biochips 10.1 Introduction 10.2 DNA analysis 10.3 Protein analysis and protein biochips 10.4 Virus detection and cell analysis 10.5 Study of the interactions between biomolecules 10.6 Detection of biological warfare agents 10.7 Environmental monitoring and cleanup 10.8 Outlook Appendix A1. Units for magnetic properties

Read more less

Book SynopsisEstablishes the criteria required to assess benefit-risk in general and reviews the current practice of benefit-risk assessment by drug regulatory authorities and the pharmaceutical industry. Outlines how the new MCDA model was developed and evaluated, and discusses the implications of its implementation into the practice of drug evaluation.Table of ContentsForeword. Preface. 1 Concept and Scope of Benefit–Risk Evaluation of Medicines. 1.1 Historical backgroun. 1.2 The regulatory systems for assessing medicines. 1.3 Benefit–risk assessment: definitions. 1.4 Views and perceptions of benefits and risks of medicines. 1.5 Stages and concepts in benefit–risk assessment. 1.6 Benefit–risk assessment: the current regulatory environment. 1.7 Benefit–risk assessment in other disciplines. 1.8 Specific methods and models for benefit–risk assessment. 1.9 Discussions with stakeholders on the concepts and models for benefit–risk evaluation. 2 Criteria for a Benefit–Risk Model: a Conceptual Framework. 2.1 Introduction. 2.2 Regulatory guidelines on benefit and risk criteria. 2.3 Identification, definition and rationale of relevant benefit and risk criteria. 2.4 Verification of the list of benefit and risk criteria by means of a survey. 3 Review of the Current Benefit–Risk Assessment Models. 3.1 Background. 3.2 Evaluation of the existing benefit–risk assessment models. 3.3 Review of models in single clinical trials and for specific medicines. 3.4 Conclusion. 3.5 Newer models. 4 Defining a Systematic Approach to Decision Making. 4.1 Introduction. 4.2 Objectives and features of the ideal model for benefit–risk assessment. 4.3 The use of decision-analysis techniques for the development of the new model. 5 Development and Application of a Benefit–Risk Assessment Model Based on Multi-Criteria Decision Analysis. 5.1 Introduction. 5.2 Conceptualization of the new model. 5.3 Reasons for using decision analysis techniques in the new model. 5.4 The use of MCDA in the new model. 5.5 Development of the new model. 5.6 Applicability of the new model. 5.7 Summary. 5.8 Review of the MCDA model. 6 A Future Framework for Benefit–Risk Appraisal of Medicines. 6.1 Background. 6.2 Development of a benefit–risk framework for regulatory review of new medicines. 6.3 Prerequisites of a benefit–risk framework for the registration of a new medicine. 6.4 Current status of benefit–risk assessment among companies and agencies. 6.5 Constructing a benefit–risk framework. 6.6 Conclusion. Appendices. Appendix 1 Summary Reports of the CMR International Institute for Regulatory Science March 2004 and June 2005 Workshops on Benefit–Risk. Appendix 2 Office of Health Economics Briefing: Challenges and Opportunities for Improving Benefit–risk Assessment of Pharmaceuticals from an Economic Perspective – James Cross and Louis Garrison (August 2008). Appendix 3 Reflection Paper on Benefit–risk Assessment Methods in the Context of the Evaluation of Marketing Authorisation Applications of Medicinal Products for Human Use – Committee for Medicinal Products for Human Use (March 2008). Appendix 4 Commentaries on ‘A Quantitative Approach to Benefit–risk Assessment of Medicines’ Pharmacoepidemiology and Drug Safety, 2007, 16. Appendix 5 Forum on Benefit: Risk Decision Analysis – Summary of Discussions and Recommendations – MHRA (September 2008). References. Index.

Read more less

Book SynopsisThe publication of this fourth edition, more than ten years on from the publication of Radiation Therapy Physics third edition, provides a comprehensive and valuable update to the educational offerings in this field. Led by a new team of highly esteemed authors, building on Dr Hendee's tradition, Hendee's Radiation Therapy Physics offers a succinctly written, fully modernised update. Radiation physics has undergone many changes in the past ten years: intensity-modulated radiation therapy (IMRT) has become a routine method of radiation treatment delivery, digital imaging has replaced film-screen imaging for localization and verification, image-guided radiation therapy (IGRT) is frequently used, in many centers proton therapy has become a viable mode of radiation therapy, new approaches have been introduced to radiation therapy quality assurance and safety that focus more on process analysis rather than specific performance testing, and the explosion in patient-anTrade Review"The book is well structured and gives an excellent overview on all practical aspects of modern radiotherapy and the physics involved. The many examples and problems allow for immediate check of the understanding of the text and make it fun to read. The new editors certainly did a very good job in carrying on the tradition of the original book" Physica Medica, Feb 2017. Full review available here "The newly published fourth edition of Hendee’s Radiation Therapy Physics (Authors: Todd Pawlicki, Daniel J. Scanderbeg, George Starkschall) provides an updated overview, analysis and practical guidance of the various aspects of the radiation therapy physics. Published ten years after the publication of the third edition, this book reviews all newly introduced modalities and approaches inRadiation therapy - intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), digital imaging, CT simulation, proton therapy, radiation therapy informatics. An important part of the book is the focus on the professional approaches in radiation protection, patient safety, quality assurance, quality improvement and even training for residents. The book is written by experts in the field – all three authors are well known professionals working in the field of Radiation Physics and Radiation Medicine. Throughout this book the reader finds scientific, educational and practical information from the very basics of radiation physics to the latest achievements in the field of Radiation Therapy. Each chapter is well structured, giving a good balance between the theoretical and practical aspects. The appendix is dedicated to solving practical problems and provides professional advice, as well as self-tests......This book is both an excellent reference which will be useful in all medical physics departments and at the same time a perfect guidance material for professionals in related specialties. It continues very well the line set by Prof. William Hendee (past IOMP ExCom member). The Content and Structure of the book are excellent. These are really necessary for a book with such coverage and volume. Thefourth edition of Hendee’s Radiation Therapy Physics is yet another fundamental book that will be very useful reference for various specialists for many yearsahead" - Medical Physics World 2016Table of ContentsPreface to the Fourth Edition, vi Preface to the Third Edition, vii Preface to the Second Edition, viii Preface to the First Edition, ix 1 Atomic Structure and Radioactive Decay, 1 2 Interactions of X Rays and Gamma Rays, 16 3 Interactions of Particulate Radiation with Matter, 29 4 Machines for Producing Radiation, 35 5 Measurement of Ionizing Radiation, 57 6 Calibration of Megavoltage Beams of X Rays and Electrons, 77 7 Central-axis Point Dose Calculations, 96 8 External Beam Dose Calculations, 110 9 External Beam Treatment Planning and Delivery, 123 10 The Basics of Medical Imaging, 146 11 Diagnostic Imaging and Applications to Radiation Therapy, 154 12 Tumor Targeting: Image-guided and Adaptive Radiation Therapy, 170 13 Computer Systems, 182 14 Radiation Oncology Informatics, 197 15 Physics of Proton Radiation Therapy, 204 16 Sources for Implant Therapy and Dose Calculation, 215 17 Brachytherapy Treatment Planning, 231 18 Radiation Protection, 248 19 Quality Assurance, 267 20 Patient Safety and Quality Improvement, 294 Appendix: Answers to Selected Problems, 310 Index, 317

Read more less

Book SynopsisThis book is a compilation of summarized analytical methods designed to serve the needs of pharmacologists, toxicologists, and other allied health professionals involved the development, use, or monitoring of pharmaceuticals. The summaries are structured monographs on 511 different drug entities detailing 964 different analytical methods, providing the reader with a thorough description of method validation. These analytical methods include not only high performance liquid chromatography (HPLC), but also gas chromatography (GC), immunoassay, electrophoresis, ultra performance liquid chromatography (UPLC) coupled with UV (UPLC-UV) detection and mass spectrometry (UPLC-MS/MS). With more detailed and complete summariesthan sketchy and abbreviated formats used in the other books, this book provides a thorough description of method validation and results, as well as the operating parameters.Trade Review"This book is valuable for pharmacologists, toxicologists, and health professionals working in academic, industrial, and regulatory agencies who are involved in therapeutic drug monitoring. . . This is a comprehensive sourcebook that details 964 different analytical methods for 511 different drugs." (Doody's, 9 September 2011) "This is an important reference for students and professionals involved with barley research, production, trade, and utilization. Editor Ullrich is an agronomist affiliated with Washington State U." (Booknews, 1 April 2011) Table of ContentsPreface. MONOGRAPHS. Abacavir. Abecarnil. Acamprosate Calcium. Acebutolol Hydrochloride. Aceclofenac. Acemetacin. Acenocoumarol. Acetaminophen. Acetazolamide. Aconitine. Acrivastine. Acyclovir. Albendazole. Albuterol. Alcuronium Chloride. Alfentanil Hydrochloride. Alfuzosin Hydrochloride. Allobarbital. Allopurinol. Alprazolam. Alprenolol. Ambroxol Hydrochloride. Amikacin. Amiloride Hydrochloride. Amiodarone Hydrochloride. Amisulpride. Amitriptyline Hydrochloride. Amlodipine Besylate. Amobarbital. Amoxapine. Amoxicillin. Amphetamine. Amphotericin B. Ampicillin. Amprenavir. Amsacrine. Apomorphine Hydrochloride. Aripiprazole. Arotinolol Hydrochloride. Artemisinin. Artesunate. Aspirin. Atazanavir Sulfate. Atenolol. Azathioprine. Azithromycin. Baclofen. Barbital. Benactyzine Hydrochloride. Bendroflumethiazide. Benzthiazide. Benzylpenicillin Potassium. Betaxolol Hydrochloride. Biapenem. Bisoprolol Fumarate. Bromazepam. Bromisoval. Bromperidol. Brompheniramine Maleate. Buflomedil Hydrochloride. Bumetanide. Buparvaquone. Bupivacaine Hydrochloride. Buprenorphine. Bupropion Hydrochloride. Buspirone Hydrochloride. Busulfan. Caffeine. Candesartan Cilexetil. Canrenone. Capecitabine. Capreomycin Sulfate. Carbamazepine. Carbidopa. Carbinoxamine Maleate. Carboplatin. Carbromal. Carteolol Hydrochloride. Carvedilol. Caspofungin Acetate. Cathine. Cefaclor. Cefadroxil. Cefalexin. Cefazolin Sodium. Cefdinir. Cefditoren Pivoxil. Cefepime Hydrochloride. Cefixime. Cefotaxime Sodium. Cefozopran Hydrochloride. Cefpiramide. Cefpirome Sulfate. Cefpodoxime Proxetil. Cefprozil. Ceftazidime. Ceftibuten. Ceftiofur Hydrochloride. Ceftizoxime Sodium. Ceftriaxone Sodium. Cefuroxime. Celecoxib. Celiprolol Hydrochloride. Cephalexin Hydrochloride. Cetirizine Hydrochloride. Chloramphenicol. Chlordiazepoxide. Chlorhexidine Acetate. Chlorothiazide. Chlorphenamine Maleate. Chlorpromazine. Chlorpropamide. Chlorthalidone. Cilnidipine. Cimetidine. Ciprofloxacin. Cisapride. Cisplatin. Citalopram Hydrobromide. Clarithromycin. Clavulanate Potassium. Clemastine Fumarate. Clenbuterol Hydrochloride. Clinafloxacin Hydrochloride. Clobazam. Clofazimine. Clomipramine Hydrochloride. Clonazepam. Clonidine. Clopamide. Cloperastine. Clotiapine. Cloxacillin. Clozapine. Cocaine. Codeine. Cotinine. Cyclopenthiazide. Cyclophosphamide. Cyclosporine. Cyproheptadine Hydrochloride. Cytarabine. Dabigatran Etexilate. Dapsone. Daptomycin. Darunavir. Debrisoquine Sulfate. Decitabine. Delavirdine Mesylate. Derxazoxane. Desipramine Hydrochloride. Desloratadine. Dexamethasone. Dexfenfluramine Hydrochloride. Dextromethorphan Hydrobromide. Dextromoramide Tartrate. Diamorphine Hydrochloride. Diazepam. Dibenzepin Hydrochloride. Diclofenac Sodium. Diclofenamide. Dicloxacillin Sodium. Didanosine. Digoxin. Diltiazem Hydrochloride. Dimethylformamide. Dimethylsulfoxide. Diphemanil Metilsulfate. Diphenhydramine Hydrochloride. Diphenylpyraline Hydrochloride. Diprophylline. Dipyridamole. Dipyrone. Docetaxel. Donepezil Hydrochloride. Dopamine Hydrochloride. Doripenem. Dosulepin Hydrochloride. Doxapram Hydrochloride. Doxazosin Mesylate. Doxepin Hydrochloride. Doxifluridine. Doxofylline. Doxorubicin Hydrochloride. Doxycycline. Doxylamine Succinate. Droloxifene. Droperidol. Drospirenone. Ecabet Sodium. Efavirenz. Emedastine Difumarate. Emtricitabine. Enalapril Maleate. Enoxacin. Enoxolone (Glycyrrhetic Acid). Ephedrine Hydrochloride. Epinephrine. Eprosartan Mesylate. Erlotinib Hydrochloride. Ertapenem Sodium. Escitalopram Oxalate. Esmolol Hydrochloride. Estazolam. Ethacrynic Acid. Ethambutol Hydrochloride. Ethionamide. Ethosuximide. Ethotoin. Etodolac. Etoposide. Everolimus. Famotidine. Faropenem Sodium. Felbamate. Felodipine. Fenoterol. Fenretinide. Fentanyl Citrate. Fexofenadine Hydrochloride. Flavopiridol. Flecainide Acetate. Fleroxacin. Floxacillin. Fluconazole. Flucytosine. Flunarizine Hydrochloride. Flunitrazepam. Fluorouracil. Fluoxetine Hydrochloride. Flupentixol Decanoate. Fluphenazine Hydrochloride. Flurbiprofen Sodium. Fluvoxamine Maleate. Formic Acid. Furosemide. Gabapentin. Ganciclovir. Garenoxacin Mesylate. Gatifloxacin. Gemcitabine Hydrochloride. Gemfibrozil. Glibenclamide. Glimepiride. Gluconolactone. Griseofulvin. Haloperidol. Heptabarbital. Homochlorcyclizine Hydrochloride. Hydrochlorothiazide. Hydrocortisone. Ibafloxacin. Ibudilast. Ibuprofen. Ifenprodil Tartrate. Ifosfamide. Imatinib Mesylate. Imidafenacin. Imipenem. Imipramine. Indapamide. Indinavir Sulfate. Indomethacin. Iomeprol. Iprindole Hydrochloride. Irbesartan. Isepamicin. Isoniazid. Itraconazole. Kanamycin A. Ketamine Hydrochloride. Ketanserin. Ketobemidone Hydrochloride. Ketoconazole. Ketoprofen. Ketorolac Tromethamine. Ketotifen Fumarate. Labetalol Hydrochloride. Lacidipine. Lamivudine. Lamotrigine. Lansoprazole. Lapatinib Ditosylate. Lercanidipine Hydrochloride. Levetiracetam. Levocetirizine. Levodopa. Levofloxacin. Levomepromazine Hydrochloride. Levonorgestrel. Lidocaine. Lomefloxacin Hydrochloride. Lopinavir. Loratadine. Lorazepam. Losartan Potassium. Loxapine. Lysergide. Manidipine Hydrochloride. Maprotiline. Mefruside. Melitracen Hydrochloride. Meloxicam. Melperone Hydrochloride. Mepindolol Sulfate. Mercaptopurine. Meropenem. Mesalazine. Mesuximide. Metformin Hydrochoride. Methadone Hydrochloride. Methamphetamine Hydrochloride. Methcathinone. Methotrexate. Methyclothiazide. 3,4-Methylenedioxyamphetamine. 3,4-Methylenedioxymethamphetamine. Methylephedrine Hydrochloride. Metoclopramide Hydrochloride. Metolazone. Metoprolol. Metronidazole. Mexiletine Hydrochloride. Mianserin Hydrochloride. Midazolam Hydrochloride. Milnacipran Hydrochloride. Minocycline Hydrochloride. Minoxidil. Mirtazapine. Mitotane. Moclobemide. Modafinil. Montelukast Sodium. Morphine. Moxifloxacin. Mycophenolate Mofetil. Nadolol. Nafcillin Sodium. Naftifine Hydrochloride. Naproxen Sodium. Nateglinide. Nelfinavir Mesylate. Nevirapine. Nicardipine Hydrochloride. Nifedipine. Nimesulide. Nimodipine. Nisoldipine. Nitrazepam. Nitrendipine. Nizatidine. Nordazepam. Norepinephrine Bitartrate. Norfloxacin. Nortriptyline Hydrochloride. Nystatin. Octopamine. Ofloxacin. Olanzapine. Olopatadine Hydrochloride. Omeprazole. Opipramol Hydrochloride. Orphenadrine Citrate. Oxacillin Sodium. Oxazepam. Oxcarbazepine. Oxolinic Acid. Oxprenolol Hydrochloride. Paclitaxel. Paroxetine. Pasiniazide. Pefloxacin Mesylate. Pemoline. Penciclovir. Pentazocine Hydrochloride. Pentisomide. Pentobarbital. Pentoxifylline. Perazine Dimalonate. Perifosine. Perphenazine. Pethidine Hydrochloride. Phenazone. Phencyclidine Hydrochloride. Phenethylamine. Pheneturide. Phenobarbital Sodium. Penicillin V. Phenprocoumon. Phenylethanolamine. Phenytoin. Pimozide. Pindolol. Pipamperone. Piperacillin Sodium. Pipethanate Ethobromide. Pirarubicin. Piroxicam. Posaconazole. Prednisolone. Pregabalin. Primidone. Probenecid. Procainamide Hydrochloride. Proguanil Hydrochloride. Promethazine Hydrochloride. Propofol. Propranolol Hydrochloride. Protionamide. Protriptyline Hydrochloride. Pseudoephedrine. Pyrazinamide. Pyrimethamine. Quetiapine Fumarate. Quinethazone. Quinine Sulfate. Raltegravir Potassium. Ranitidine Hydrochloride. Reboxetine Mesylate. Resveratrol. Ribavirin. Rifampin. Rifapentine. Riluzole. Risperidone. Ritonavir. Rizatriptan Benzoate. Rofecoxib. Rogletimide. Ropivacaine Hydrochloride. Salicylic Acid. Saquinavir. Secbutabarbital Sodium. Secobarbital Sodium. Serotonin. Sertraline Hydrochloride. Sildenafil Citrate. Sirolimus. Sodium Valproate. Sotalol Hydrochloride. Sparfloxacin. Spironolactone. Stavudine. Sufentanil Citrate. Sulfadiazine. Sulfadoxine. Sulfamerazine. Sulfamethizole. Sulfamethoxazole. Sulfaquanidine. Sulpiride. Sultopride Hydrochloride. Sumatriptan Succinate. Tacrine Hydrochloride. Tacrolimus. Tadalafil. Tamoxifen Citrate. Tegaserod Maleate. Telithromycin. Telmisartan. Temazepam. Teniposide. Tenofovir. Terazosin Hydrochloride. Terbutaline Sulfate. Tertatolol Hydrochloride. Testosterone. Tetracaine Hydrochloride. Theobromine. Theophylline. Thioguanine. Thioridazine. Thiotepa. Tiapride Hydrochloride. Timolol Maleate. Tipranavir. Tobramycin. Tolbutamide. Toloxatone. Topiramate. Toremifene Citrate. Torsemide. Tosufloxacin. Tramadol Hydrochloride. Triamterene. Triazolam. Trimethoprim. Trimipramine. Triprolidine Hydrochloride. Tryptophan. Tyramine Hydrochloride. Valacyclovir Hydrochloride. Valganciclovir Hydrochloride. Valproic Acid. Vancomycin Hydrochloride. Venlafaxine Hydrochloride. Verapamil Hydrochloride. Vigabatrin. Viloxazine Hydrochloride. Vincristine Sulfate. Vinorelbine Tartrate. Voriconazole. Vorinostat. Warfarin Sodium. Zalcitabine. Zidovudine. Zolmitriptan. Zonisamide. Zopiclone. Zotepine. Zuclopenthixol Hydrochloride. Index.

Read more less

Book SynopsisBasics of Biomedical Ultrasound for Engineers is a structured textbook for university engineering courses in biomedical ultrasound and for researchers in the field. This book offers a tool for building a solid understanding of biomedical ultrasound, and leads the novice through the field in a step-by-step manner.Table of ContentsPreface. Acknowledgments. Introduction. Prelude and Basic Definitions. The Advantages of Using Ultrasound in Medicine. A General Statement on Safety. Some Common Applications of Ultrasound. What Is It that We Need to Know? References. 1 Waves—A General Description. 1.1 General Definitions of Waves—A Qualitative Description. 1.2 General Properties of Waves—A Qualitative Description. 1.3 Mechanical One-Dimensional Waves. 1.4 The Wave Function. 1.5 The Wave Equation. 1.6 Harmonic Waves. 1.7 Group Waves. 1.8 Wave Velocity. 1.9 Standing Waves (a Mathematical Description). 1.10 Spherical Waves. 1.11 Cylindrical Waves. 1.12 The Wave Equation in a Nonhomogeneous Medium. References. 2 Waves In A One-Dimensional Medium. 2.1 The Propagation Speed of Transverse Waves in a String. 2.2 Vibration Frequencies for a Bounded String. 2.3 Wave Reflection (Echo) in a One-Dimensional Medium. 2.4 Special Cases. 2.5 Wave Energy in Strings. 2.6 Propagation of Longitudinal Waves in an Isotropic Rod or String. 2.7 A Clinical Application of Longitudinal Waves in a String. References. 3 Ultraspmoc Waves in Fluids. 3.1 Waves in Fluids. 3.2 Compressibility. 3.3. Longitudinal Waves in Fluids. 3.4 The Wave Energy. 3.5 Intensity. 3.6 Radiation Pressure. 3.7 A Perfect Reflector. References. 4 Propogation of Acoustic Waves in Solid Materials. 4.1 Introduction to the Mechanics of Solids. 4.2 The Elastic Strain. 4.3 Stress. 4.4 Hooke’s Law and Elastic Coefficients. 4.5 The Wave Equation for an Elastic Solid Material. 4.6 Propagation of a Harmonic Planar Wave in a Solid Material. References. 5 Attenuation and Dispersion. 5.1 The Attenuation Phenomenon. 5.2 Explaining Attenuation with a Simple Model. 5.3 Attenuation Dependency on Frequency. 5.4 The Complex Wave Number. 5.5 Speed of Sound Dispersion. 5.6 The Nonlinear Parameter B/A. References. 6 Reflection and Transmission. 6.1 The Acoustic Impedance. 6.2 Snell’s Law. 6.3 Reflection and Transmission from Boundaries Separating Two Fluids (or Solids with No Shear Waves). 6.4 Reflection from a Free Surface in Solids (Mode Conversion). 6.5 Reflection and Transmission from a Liquid– Solid Boundary. References. 7 ACOUSTIC LENSES AND MIRRORS. 7.1 Optics. 7.2 Optics and Acoustics. 7.3 An Ellipsoidal Lens. 7.4 Spherical Lenses. 7.5 Zone Lenses. 7.6 Acoustic Mirrors (Focusing Reflectors). References. 8 Transducers and Acoustic Fields. 8.1 Piezoelectric Transducers. 8.2 The Acoustic Field. 8.3 The Field of a Point Source. 8.4 The Field of a Disc Source. 8.5 The Field of Various Transducers. 8.6 Phased-Array Transducers. 8.7 Annular Phased Arrays. References. 9 Ultrasonic Imaging Using the Pulse-Echo Technique. 9.1 Basic Definitions in Imaging. 9.2 The “A-Line”. 9.3 Scatter Model for Soft Tissues. 9.4 Time Gain Compensation. 9.5 Basic Pulse-Echo Imaging (B-Scan). 9.6 Advanced Methods for Pulse-Echo Imaging. References. 10 Special Imaging Techniques. 10.1 Acoustic Impedance Imaging—Impediography. 10.2 Elastography. 10.3 Tissue Speckle Tracking. 10.4 Through-Transmission Imaging. 10.5 Vibro-acoustic Imaging. 10.6 Time Reversal. 10.7 Ultrasonic Computed Tomography. 10.8 Contrast Materials. 10.9 Coded Excitations. References. 11 Doppler Imaging Techniques. 11.1 The Doppler Effect. 11.2 Velocity Estimation. 11.3 Frequency Shift Estimation. 11.4 Duplex Imaging (Combined B-Scan and Color Flow Mapping). References. 12 Safety and Therapuetic Applications. 12.1 Effects Induced by Ultrasound and Safety. 12.2 Ultrasonic Physiotherapy. 12.3 Lithotripsy. 12.4 Hyperthermia HIFU and Ablation. 12.5 Drug Delivery. 12.6 Gene Therapy. 12.7 Cosmetic Applications. References. Appenidx A: Typical Acoustic Properties of Tissues. Appendix B: Exemplary Problems. Appendix C: Answers to Exemplary Problems. Index.

Read more less

Book Synopsis Organised according to presenting signs, with discussion of appropriate investigations Outlines strengths and weaknesses of different imaging modalities and discusses appropriate choice of technique in each instance Reviews differential diagnoses and corroborative tests Table of ContentsForeword xiii Preface xv Contributors xvii 1 Adrenal Imaging 1Khaled M. Elsayes, Isaac R. Francis, Melvyn Korobkin and Gerard M. Doherty 1.1 Introduction 1 1.2 Cushing’s syndrome 2 1.3 Primary hyperaldosteronism 5 1.4 Pheochromocytoma 8 1.5 Adrenal cortical carcinoma 12 1.6 Adrenal incidentaloma 15 2 Retroperitoneal Masses 21Pietro Pavlica, Massimo Valentino and Libero Barozzi 2.1 Introduction 21 2.2 Retroperitoneal anatomy 21 2.3 Pathological conditions 22 2.4 Primary solid retroperitoneal tumors 22 2.5 Retroperitoneal lymphoma 27 2.6 Cystic retroperitoneal masses 30 2.7 Retroperitoneal metastases 32 2.8 Retroperitoneal fibrosis (Ormond’s disease) 33 2.9 Retroperitoneal fluid collections (traumatic and non-traumatic) 35 References 41 3 Imaging of Renal Artery Stenosis 43Robert Hartman 3.1 Introduction 43 3.2 Clinical features 43 3.3 Pathology 45 3.4 Imaging of suspected renal artery stenosis 45 References 51 4 Renal Masses 53Philip J. Kenney 4.1 Introduction 53 4.2 Symptomatic renal carcinoma 53 4.3 Incidental renal masses 55 4.4 Patients with a known cancer (other than RCC) 62 4.5 Renal mass in patients with symptoms 63 4.6 Vascular lesions presenting as a renal mass 68 4.7 Renal mass in patients with cystic disease 72 4.8 Treatment 73 References 73 5 Non-neoplastic Renal Cystic Lesions 75Sameh K. Morcos 5.1 Introduction 75 5.2 Classification 75 5.3 Cystic lesions affecting renal cortex 76 5.4 Cystic lesions of renal medulla 80 5.5 Cystic diseases affecting both the cortex and medulla 86 References 97 6 Urological and Vascular Complications Post-renal Transplantation 99Tarek El-Diasty and Yasser Osman 6.1 Introduction 99 6.2 Vascular complications 99 6.3 Urological complications 107 6.4 Ureteric strictures 110 6.5 Post-transplant lymphocele 113 6.6 Delayed graft function (DGF) 116 6.7 Post-transplant bladder malignancy 119 References 120 7 Urinary Tract Injuries 121Elliott R. Friedman, Stanford M. Goldman and Tung Shu 7.1 Introduction 121 7.2 Renal trauma 121 7.3 Adrenal trauma 130 7.4 Ureteral trauma 131 7.5 Bladder trauma 133 7.6 Urethral trauma 136 7.7 Penile and scrotal trauma 142 References 147 8 Urinary Tract Infections 149Mikael Hellström, Ulf Jodal, Rune Sixt and Eira Stokland 8.1 Symptomatic urinary tract infection in children 149 8.2 Symptomatic upper urinary tract infection in adults 167 8.3 Emphysematous pyelonephritis 173 8.4 Xanthogranulomatous pyelonephritis 174 8.5 Urinary tract infection in the immunocompromised patient 177 8.6 Tuberculosis 179 8.7 Schistosomiasis 183 8.8 Hydatid disease (echinococcosis) 188 8.9 Urethritis 191 References 193 9 Imaging of the Genitourinary System – Urolithiasis 195Sami A Moussa and Paramananthan Mariappan 9.1 Introduction 195 9.2 Pathology 195 9.3 Clinical features 197 9.4 Evaluation of patients with suspected urinary stones 198 9.5 Treatment 198 9.6 Imaging 199 References 218 10 Hematuria 219Thomas Bretlau, Kirstine L. Hermann, Jørgen Nordling and Henrik S. Thomsen 10.1 Definition 219 10.2 Clinical considerations 219 10.3 Diagnosis of hematuria 220 10.4 Epidemiology 220 10.5 Distribution of malignancy in patients with hematuria 223 10.6 Imaging 223 10.7 Summary 230 References 234 11 Bladder Cancer 235G. Heinz-Peer and C. Kratzik 11.1 Introduction 235 11.2 Clinical features 237 11.3 Pathology 239 11.4 Imaging findings 243 11.5 Treatment planning 253 11.6 Post-treatment Imaging 254 11.7 Summary 254 References 255 12 Imaging of Urinary Diversion 257Sameh Hanna and Hesham Badawy 12.1 Introduction 257 12.2 Indications for urinary diversion 257 12.3 Types of urinary diversion 257 12.4 Non-continent cutaneous form of diversion 258 12.5 Continent cutaneous urinary diversion (Continent Catheterizing Pouches) 258 12.6 Non-orthotopic continent diversion, relying on the anal sphincter for continence 260 12.7 Orthotopic form of diversion to the native, intact urethra (neobladder) 261 12.8 Contraindications to urinary diversion 264 12.9 Complications of urinary diversions 264 12.10 The role of radiologist in urinary diversion includes 267 12.11 Imaging studies 268 12.12 Imaging of complications 269 12.13 Summary 271 References 271 13 Imaging of the Prostate Gland 273François Cornud 13.1 Introduction 273 13.2 Zonal anatomy and benign prostatic hypertrophy 273 13.3 Diagnosis of prostate cancer: TRUS features 276 13.4 Diagnostic of prostate cancer: MRI 284 13.5 Contrast-enhanced (dynamic) MRI 285 13.6 Magnetic Resonance Spectroscopic Imaging (MRSI) 290 13.7 Diffusion-weighted imaging 292 13.8 Indications of functional MRI 295 13.9 Extension of prostate cancer 297 13.10 Local extension by TRUS and TRUS-guided biopsy 297 13.11 MRI and staging of prostate cancer 298 13.12 Local staging 299 13.13 Lymph node metastases: lympho-MRI 304 13.14 Bone metastases: whole marrow MRI 304 13.15 Benign disorders of the prostate (BPH excluded) 305 References 321 14 Haemospermia 323Drew A. Torigian, Keith N. Van Arsdalen and Parvati Ramchandani 14.1 Introduction 323 14.2 Clinical features 323 14.3 Pathology 325 14.4 Imaging findings 325 14.5 Summary 337 References 337 15 Scrotal Masses 339Lorenzo E. Derchi and Alchiede Simonato 15.1 Introduction 339 15.2 Clinical features 339 15.3 Pathology 340 15.4 Imaging 340 15.5 Important principles in assessment of scrotal masses 341 15.6 Important problems in differentiating benign from malignant lesions 345 References 350 16 Gynaecological Adnexal Masses 351John A. Spencer and Michael J. Weston 16.1 Introduction 351 16.2 Clinical features 351 16.3 Pathology 352 16.4 Imaging 354 16.5 Standard radiographic techniques 355 16.6 Ultrasound (US) 355 16.7 MR Imaging (MRI) 366 16.8 Computed Tomography 373 References 379 17 Imaging of Abnormal Uterine Bleeding 381Patricia Noël, Evis Sala and Caroline Reinhold 17.1 Abnormal uterine bleeding 381 17.2 Adenomyosis 382 17.3 Leiomyomas 385 17.4 Endometrial polyp 389 17.5 Endometrial hyperplasia 391 17.6 Endometrial carcinoma 394 17.7 Summary 396 References 397 18 Female Pelvic Floor Dysfunction 399Rania Farouk El Sayed 18.1 Introduction 399 18.2 Anatomical considerations 399 18.3 Pathophysiology of pelvic floor dysfunction 401 18.4 Clinical features 401 18.5 Imaging of pelvic floor dysfunction 404 18.6 Magnetic resonance imaging (MRI) 407 References 413 19 Imaging of female infertility 415Ahmed-Emad Mahfouz and Hanan Sherif 19.1 Introduction 415 19.2 Polycystic ovary syndrome 415 19.3 Abnormalities of the fallopian tubes (Hydrosalpinx/Hematosalpinx, tubal block) 418 19.4 Fibroids 421 19.5 Adenomyosis 423 19.6 Developmental anomalies of the uterus 424 19.7 Endometriosis 429 19.8 Imaging 430 Index 431

Read more less

Book SynopsisThis book provides a thorough yet concise introduction to quantitative radiobiology and radiation physics, particularly the practical and medical application.Trade Review“This is a very comprehensive text that goes far beyond the content most would expect given the rather specific title.” (Scope, 1 March 2015) Table of ContentsAcknowledgments vii Introduction ix 1 Anatomy and Physiology 1 2 The Cell 19 3 Radiation Characteristics and Units 41 4 Radiation Interactions with Tissue 61 5 Cell Survival Curves 81 6 Dna and Genetics 105 7 Radiation Damage and Repair of Cells 125 8 Normal and Malignant Cells 145 9 Radiation Effects on Tissues and Organs 161 10 Whole Body Radiation Effects 179 11 Radiation Treatment of Cancer 191 12 Radiation Biology of Diagnostic Imaging 203 13 Nuclear Medicine Radiation Biology 219 14 Environmental Radiation 241 15 Regulations and Risk 255 16 Biological Effects of Ultrasound 269 17 Biological Effects of Magnetic Resonance Imaging 281 Answers to Odd-numbered Questions 297 Index 301

Read more less

Book SynopsisThis book provides students, teachers, researchers, and clinicians with a strong and established source of information on advanced optical technologies that show real promise of being translated to clinical use.Table of ContentsContributors. Preface. 1 Introduction to Optical Imaging in Clinical Medicine (Nicusor Iftimia, Daniel X. Hammer, and William R. Brugge). 2 Traditional Imaging Modalities in Clinical Medicine (Ileana Iftimia and Herbert Mower). 3 Current Imaging Approaches and Further Imaging Needs in Clinical Medicine: A Clinician’s Perspective (Gadi Wollstein and Joel S. Schuman, Cetin Karaca, Sevdenur Cizginer, and William R. Brugge, Ik-Kyung Jang and Jin-Man Cho, Peter K. Dempsey). 4 Advances in Retinal Imaging (Daniel X. Hammer). 5 Confocal Microscopy of Skin Cancers (Juliana Casagrande Tavoloni Braga, Itay Klaz, Alon Scope, Daniel Gareau, Milind Rajadhyaksha, and Ashfaq A. Marghoob). 6 High-Resolution Optical Coherence Tomography Imaging in Gastroenterology (Melissa J. Suter, Brett E. Bouma, and Guillermo J. Tearney). 7 High-Resolution Confocal Endomicroscopy for Gastrointestinal Cancer Detection (Jonathan T. C. Liu, Jonathan W. Hardy, and Christopher H. Contag). 8 High-Resolution Optical Imaging in Interventional Cardiology (Thomas J. Kiernan, Bryan P. Yan, Kyoichi Mizuno, and Ik-Kyung Jang). 9 Fluorescence Lifetime Spectroscopy in Cardio and Neuroimaging (Laura Marcu, Javier A. Jo, and Pramod Butte). 10 Advanced Optical Methods for Functional Brain Imaging: Time-Domain Functional Near-Infrared Spectroscopy (Alessandro Torricelli, Davide Contini, Lorenzo Spinelli, Matteo Caffini, Antonio Pifferi, and Rinaldo Cubeddu). 11 Advances in Optical Mammography (Xavier Intes and Fred S. Azar). 12 Photoacoustic Tomography (Huabei Jiang and Zhen Yuan). 13 Optical Imaging and Measurement of Angiogenesis (Brian S. Sorg). 14 High-Resolution Phase-Contrast Optical Coherence Tomography for Functional Biomedical Imaging (Taner Akkin and Digant P. Davé). 15 Polarization Imaging (Mircea Mujat). 16 Nanotechnology Approaches to Contrast Enhancement in Optical Imaging and Disease-Targeted Therapy (Nicusor Iftimia, Lara Milane, Amy Oldenburg, and Mansoor Amiji). 17 Molecular Probes for Optical Contrast Enhancement of Gastrointestinal Cancers (Jonathan W. Hardy, Anson W. Lowe, Christopher H. Contag, and Jonathan T. C. Liu). Index.

Read more less

Book SynopsisPleural diseases are very common and of increasing prevalence. This brand new title in the ABC series covers a wide range of conditions including pneumothorax, pleural effusions, pleural infections, chylothorax and mesothelioma.Table of ContentsContributors vii 1 Anatomy and Physiology of the Pleura 1John P. Corcoran and Najib M. Rahman 2 Radiology of Pleural Disease 5Rob J. Hallifax, John P. Corcoran and Najib M. Rahman 3 Pneumothorax 9John Harvey, Andrew McDuff and Ian Hunt 4 Investigation of Pleural Effusions 13Clare E. Hooper 5 Pleural Pathology 21Brendan Tinwell and Ian Hunt 6 Unusual Causes of Pleural Disease 29David Feller]Kopman 7 Pleural Infection 33Ian Hunt and Najib M. Rahman 8 Management of Malignant Pleural Effusions 39Anna C. Bibby, Nick A. Maskell and Rahul Bhatnagar 9 Malignant Mesothelioma 47Carol Tan, Fergus V. Gleeson and Y.C. Gary Lee 10 Pleural Interventions Section A: Pleural Aspiration 53Ambika Talwar, Ahmed Yousuf and Najib M. Rahman Section B: Chest Drain Insertion 56Ahmed Yousuf and Najib M. Rahman Section C: Insertion of an Indwelling Pleural Catheter 60Anna C. Bibby and Nick A. Maskell 11 Medical Thoracoscopy Section A: Rigid Thoracoscopy 63Matthew Evison, Ambika Talwar, Ahmed Yousuf and Mohammed Munavvar Section B: Semi]Rigid Thoracoscopy 69Matthew Evison and Mohammed Munavvar 12 Surgical Management of Pleural Disease 73Stephanie Fraser and Ian Hunt Index 77

Read more less

Book SynopsisFor Junior Doctors, Specialty Trainees, and all those involved in hospital governance, this book offers the ultimate real-life guide to help tackle the professional and emotional challenges of life as a doctor in paediatrics. Unlike other clinical management titles, this book identifies and explains the most common and important medical errors.Trade Review“My experience as an expert witness in clinical negligence cases, MPTS Panel chairman, medical adviser to a Public Inquiry and as a sometimes commissioned independent reporter on adverse incidents tells me that these are excellent books, valuable for all clinicians, not just those in high-risk specialties; and all NHS managers involved in maintaining or improving the quality of care. The case vignettes, alone, are useful source material for teaching medical trainees on what can go wrong and how to deal with it when it does.” (Harvey Marcovitch, Clinical Risk journal) "This book is well written and easily read. It is divided into three main parts. The first part deals in general terms with the areas in which errors tend to occur. The importance of good communication, both written and oral, is repeatedly stressed. The contribution of poor management and of system errors in the creation of problems is not overlooked. The section on legal aspects of errors, including discussion of negligence, consent and confidentiality is concise and clear. The second part consists of thirty-six case studies. These are interesting and thought provoking, with questions for the reader at significant points in the progress of each case. An expert opinion, legal comment and key learning points are given at the conclusion of each case. Part 3 gives information and advice on responding to complaints, managing mishaps and navigating the hazards of police, court and GMC involvement. Again it is concise and helpful. After sections 1 and 3, and after every case study in section 2, references and suggestions for further reading are given. I would strongly recommend this book to all paediatricians, at all levels. It is well structured, easy to read and informative. I would also like to see medical and non-medical managers reading it, as it puts into perspective the role of system failures that so often contribute significantly to clinical errors. I think that general practitioners would also find it well worth reading." (Hilary Haines, F.R.C.P.C.H., F.F.P.H.) Pre-publication reviews: “I think in Medicine it is always best to learn from others’ mistakes rather than waiting until you make your own. In addition, knowing what you can expect if a complaint is made goes some way to emphasising the importance of avoiding errors in the first place. Should a complaint be made, forewarned is forearmed.” (ST1 in Paediatrics) “The format of presenting “real life” cases with expert clinical and legal commentary is both entertaining and highly informative.” (Consultant Paediatrician)Table of ContentsContributors, viii Foreword, ix Abbreviations, xi Introduction, xiii Part 1 Section 1: Errors and their causes A few words about error, 1 Learning from system failures – the vincristine case, 1 Person-centred paediatric errors and their causes, 8 The patient consultation, 10 Failure to identify a sick child, 12 Inability to perform practical procedures competently, 13 Failure to check test results or act on abnormal findings, 15 Prescribing errors, 16 Failures in resuscitation, 17 Sources of error in child protection cases, 19 References and further reading, 22 Section 2: Medico-legal aspects Error in a legal context, 25 Negligence, 25 Medical negligence, 26 Issues around consent, 29 Confidentiality, 34 References and further reading, 37 Part 2 Clinical cases Introduction, 39 Case 1 A boy with a limp, 40 Case 2 A fitting infant, 43 Case 3 A persistent fever, 45 Case 4 A biking injury, 48 Case 5 A teenager with abdominal pain, 51 Case 6 A young girl with a vaginal discharge, 54 Case 7 An iatrogenic problem, 57 Case 8 An infant with a large head, 59 Case 9 An infant with bloody diarrhoea, 62 Case 10 An infant with persistent jaundice, 64 Case 11 A child with leukaemia and tummy ache, 66 Case 12 A boy with fever and rigors, 68 Case 13 A stiff hand, 70 Case 14 A serious feeding problem, 72 Case 15 Fits, faints and funny turns, 74 Case 16 A hospital acquired infection, 76 Case 17 Recurrent wheeze, 79 Case 18 A jaundiced neonate, 82 Case 19 A febrile boy with a limp, 85 Case 20 A febrile neonate, 87 Case 21 A neonate with abnormal movements, 89 Case 22 A teenager with scrotal pain, 91 Case 23 A boy with nonspecific symptoms, 93 Case 24 A delayed walker, 96 Case 25 A diabetic girl with a headache, 98 Case 26 A boy with sickle cell disease and a fever, 101 Case 27 Negative test results, 104 Case 28 A bad case of ‘flu, 107 Case 29 A difficult transfer, 110 Case 30 Treatment for tonsillitis, 112 Case 31 Increasing respiratory distress, 114 Case 32 A feverish girl with poor feeding, 116 Case 33 An infant with a swollen face, 118 Case 34 Starting a new treatment, 121 Case 35 The importance of interpretation, 124 Case 36 A febrile boy with a scald, 126 Part 3 Investigating and dealing with errors 1 Introduction, 129 2 How hospitals try to prevent errors and their recurrence, 129 3 The role of hospital staff, 134 4 External investigators, 136 5 Hospital investigations, 138 6 Legal advice – where to get it and how to pay, 143 7 External inquiries, 146 8 The role of the doctor, 165 9 Emotional repercussions, 167 10 Conclusion, 169 References and further reading, 169 Index, 171

Read more less

Book SynopsisEthical medical practice and treatment in psychiatry are based on the concept of first do no harm. However, this cannot, and does not, apply to forensic cases where there is no doctorpatient relationship and the forensic psychiatrist may indeed cause harm to the examinee. In this book, Robert Sadoff analyzes the ethical issues affecting forensic psychiatric practice, especially those promulgated by the American Academy of Psychiatry and the Law. Within those guidelines, he looks at individual bias, vulnerability of the examinee, and potential harm to the mental health professional. The book discusses each of the procedures of the forensic expert separately with respect to minimizing harm. It has been written with an international audience in mind and features chapters reviewing the European and UK perspectives, by Emanuele Valenti and John Baird, respectively. Robert Sadoff addresses the long-term harm that can be either avoided or minimized through careful planning and applicationTrade Review"Sadoff's book is a vital contribution to the psychiatric literature, as it fills a need unaddressed by more theoretically oriented works. Anyone interested in mental health or medical ethics will find this text worthwhile, especially as it contains an introduction for lay readers explaining basic forensic roles and functions.The book is most valuable, however, to forensic mental health practioners, who will benefit from its practical instruction aimed at minimizing harm." (Journal of Clinical Psychiatry, December 2012) "Sadoff has crafted an admirable mix of facts and anecdotes, presented in a manner that could help undergraduates get a taste for the realities of forensic practice, help graduate students connect the theoretical with the practical, and even provide veteran practitioners with helpful reminders and provocative food for thought." (PsycCRITIQUES, 23 November 2011) "It will serve as a useful resource and is a welcome addition to my library." (Doody's, 11 November 2011) "While Ethical Issues in Forensic Psychiatry appears to be targeted at the forensic psychiatrist, as emphasised in the title, I believe that it can be valuable reading for all forensic mental health professionals. . . Ethical Issues in Forensic Psychiatry makes practical ethics easy reading. . . This book is an invaluable guide to ethical practice." (Journal of Mental Health, 1 October 2011) Table of ContentsAbout the Authors. Preface. Acknowledgments. Introduction. List of Contributors. Part One Ethics in Forensic Psychiatry. 1 Ethical Issues in Forensic Psychiatry in the United States (Robert L. Sadoff). 2 Minimizing Harm: A Perspective from Forensic Psychiatry in the United Kingdom (John A. Baird). 3 Mental Health and Human Rights in Forensic Psychiatry in the European Union (Emanuele Valenti and Luis Fernando Barrios Flores). Part Two The Practice of Forensic Psychiatry. 4 The Forensic Psychiatric Examination (Robert L. Sadoff). 5 The Forensic Psychiatric Report (Robert L. Sadoff). 6 Expert Psychiatric Testimony (Robert L. Sadoff). Part Three Vulnerable Populations in the Justice System. 7 Children and Adolescents (Robert L. Sadoff). 8 The Elderly, the Mentally Retarded, and the Severely Mentally Disabled (Robert L. Sadoff). 9 Victims and Predators of Sexual Violence (Robert L. Sadoff). 10 Immigrants: A Vulnerable Population (Solange Margery Bertoglia). 11 Prisoners and Death Row Inmates (Robert L. Sadoff). 12 Forensic Psychiatric Experts: Risks and Liability (Robert L. Sadoff). 13 Risks of Harm to the Forensic Expert: the Legal Perspective (Donna L. Vanderpool). Index.

Read more less

Book SynopsisFood Allergy is a unique book which uses a scientific approach to cover both pediatric and adult adverse reactions to foods and food additives. Following the successful formula of the previous editions, Food Allergy has established itself as the comprehensive reference for those treating patients with food allergy or suspected allergy. This fifth edition has been thoroughly revised and updated. It is a practical, readable reference for use in the hospital or private practice setting. Each of the chapters is capable of standing alone, but when placed together they present a mosaic of the current ideas and research on adverse reactions to foods and food additives. The book covers basic and clinical perspectives of adverse reactions to food antigens, adverse reactions to food additives and contemporary topics, including a review of the approaches available for diagnosis. Food Allergy is directed toward clinicians, nutritionists and scientists interestTrade Review"Food Allergy: Adverse Reactions to Foods and Food Additives will be a welcome addition to libraries serving clinicians, nutritionists, dieticians and persons with food allergies or parents of children with food allergies." (Reference Reviews, 1 April 2015)Table of ContentsList of Contributors, vii Preface, xi Abbreviations, xiii Part 1 Adverse Reactions to Food Antigens: Basic Science 1 The Mucosal Immune System, 3 Shradha Agarwal & Lloyd Mayer 2 The Immunological Basis of IgE-Mediated Reactions, 16 Stephan C. Bischoff & Gernot Sellge 3 The Immunological Basis of Non-IgE-Mediated Reactions, 31 Ashraf Uzzaman & Hirsh D. Komarow 4 Food Allergens—Molecular and Immunological Characteristics, 47 Heimo Breiteneder & E.N. Clare Mills 5 Biotechnology and Genetic Engineering, 68 Gary A. Bannon, Jason M. Ward, Raymond C. Dobert, & Roy L. Fuchs 6 Food Allergen Thresholds of Reactivity, 90 Steve L. Taylor, Jonathan O’B. Hourihane, & Joseph L. Baumert 7 Immunological Tolerance, 100 Lauren Steele & M. Cecilia Berin 8 In Vitro Diagnostic Methods in the Evaluation of Food Hypersensitivity, 110 Robert G. Hamilton Part 2 Adverse Reactions to Food Antigens: Clinical Science 9 Theories on the Increasing Prevalence of Food Allergy, 123 Katrina J. Allen & Jennifer J. Koplin 10 The Spectrum of Allergic Reactions to Foods, 134 Stacie M. Jones & A. Wesley Burks 11 Cutaneous Reactions: Atopic Dermatitis and Other IgE- and Non-IgE-Mediated Skin Reactions, 144 David M. Fleischer & Donald Y.M. Leung 12 Oral Allergy Syndrome, 158 Julie Wang 13 The Respiratory Tract and Food Hypersensitivity, 169 Graham Roberts 14 Anaphylaxis and Food Allergy, 178 Hugh A. Sampson 15 Infantile Colic and Food Allergy, 192 Ralf G. Heine & David J. Hill 16 Eosinophilic Esophagitis, Gastroenteritis, and Colitis, 203 Amanda Muir & Chris A. Liacouras 17 Gluten-Sensitive Enteropathy, 217 Alberto Rubio-Tapia & Joseph A. Murray 18 Food Protein-Induced Enterocolitis and Enteropathies, 230 Jay A Lieberman & Anna Nowak-Wegrzyn 19 Occupational Reactions to Food Allergens, 245 Andre Cartier, Sangeeta J. Jain, Laurianne G. Wild, Maxcie Sikora, Matthew Aresery, & Samuel B. Lehrer Part 3 Adverse Reactions to Foods: Diagnosis 20 IgE Tests: In Vitro Diagnosis, 269 Kirsten Beyer 21 In Vivo Diagnosis: Skin Testing and Challenge Procedures, 278 Scott H. Sicherer 22 Atopy Patch Testing for Food Allergies, 289 Von Ta & Kari Nadeau 23 Elimination Diets and Oral Food Challenges, 296 Scott H. Sicherer 24 General Approach to Diagnosing Food Allergy and the Food Allergy Guidelines, 306 Jonathan O’B. Hourihane & Hugh A. Sampson 25 Hidden and Cross-Reacting Food Allergens, 316 Scott H. Sicherer 26 Controversial Practices and Unproven Methods in Allergy, 328 David R. Scott, Jennifer A. Namazy, & Ronald A. Simon Part 4 Adverse Reactions to Food Additives 27 Asthma and Food Additives, 341 Robert K. Bush & Michelle Montalbano 28 Urticaria, Angioedema, and Anaphylaxis Provoked by Food Additives, 346 John V. Bosso & David M. Robertson 29 Sulfites, 361 Steve L. Taylor, Robert K. Bush, & Julie A. Nordlee 30 Monosodium Glutamate, 375 Katharine M. Woessner 31 Tartrazine, Azo, and Non-Azo Dyes, 384 Donald D. Stevenson 32 Adverse Reactions to the Antioxidants Butylated Hydroxyanisole and Butylated Hydroxytoluene, 393 Richard W. Weber 33 Adverse Reactions to Benzoates and Parabens, 402 Raymond M. Pongonis & John M. Fahrenholz 34 Food Colorings and Flavors, 411 Matthew J. Greenhawt & James L. Baldwin Part 5 Contemporary Topics in Adverse Reactions to Foods 35 Pharmacologic Food Reactions, 439 Timothy J. Franxman & James L. Baldwin 36 The Management of Food Allergy, 452 Maria Laura Acebal, Anne Mu˜ noz-Furlong, & Hugh A. Sampson 37 The Natural History of Food Allergy, 464 Robert A. Wood 38 Prevention of Food Allergy, 475 Gideon Lack & George Du Toit 39 Diets and Nutrition, 492 Marion Groetch 40 Food Toxicology, 507 Steve L. Taylor 41 Seafood Toxins, 518 Soheil Chegini, Sarah J. Austin, & Dean D. Metcalfe 42 Neurologic Reactions to Foods and Food Additives 535 Richard W. Weber 43 Experimental Approaches to the Study of Food Allergy, 547 M. Cecilia Berin & Madhan Masilamani 44 Food Allergy: Psychological Considerations and Quality of Life, 556 Ma. Lourdes B. de Asis & Ronald A. Simon 45 Foods and Rheumatologic Diseases, 568 Lisa K. Stamp & Leslie G. Cleland 46 Approaches to Therapy in Development, 581 Anna Nowak-W_egrzyn & Hugh A. Sampson Index, 599

Read more less

Book SynopsisBipolar Disorder Bipolar disorder is the most complex psychiatric disorder with different types of mood episodes, subtypes, varied course, and significant comorbidity. Not surprisingly, this complexity poses unique challenges to clinicians for optimal management of those with bipolar disorder. There has been an explosion of research into the causes and treatment of this condition over the past two decades. It is a daunting task for a practising clinician to make sense of this research and to remain up to date with progress in the understanding of the neurobiology and treatment of bipolar disorder. This book synthesizes and translates the vast array of research knowledge into information that is both relevant and meaningful for a clinician. The book provides a comprehensive, yet focused, reference work on bipolar disorder for both trainees and practising psychiatrists. The two editors are leaders in the field who have published extensively on bipolar disorder. They have Trade Review"...The textbook is also an ideal starting point for trainees and young investigators just beginning to explore these subjects. Biopolar Disorder: Clinical and Neurobiological Foundations, then, is a useful addition to the library of most clinicians and academic psychiatrists" (Journal of Clinical Psychiatry, 2011) "The book is a valuable guide to every psychiatrist. It contains a rich and wide range of information about bipolar disorder, step by step from criteria and definitions through biological changes to medical and psychotherapeutic treatment. The reader gets an overview over the newest findings which are presented in a very accessible way. It is definitely a book necessary for each modern psychiatrist!" (Acta Psychiatrica Scandinavica, 2011) "Contributors to 38 chapters offer international perspectives on the disorder's clinical and neurobiological foundations as defined by the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders and the International Classification of Diseases." (SciTech Book News, December 2010) Table of ContentsPreface. List of Contributors. 1 From Mania to Bipolar Disorder (David Healy). 2 Clinical Features and Subtypes of Bipolar Disorder (Fred K. Goodwin and D.Z. Lieberman). 3 The Long-Term Course and Clinical Management of Bipolar I and Bipolar II Disorders (Lewis L. Judd and Pamela J. Schettler). 4 Comorbidity in Bipolar Disorder: A Focus on Addiction and Anxiety Disorders (Mark A. Frye and Giulio Perugi). 5 DSM-V Perspectives on Classification of Bipolar Disorder (Jan Fawcett). 6 Update on the Epidemiology of Bipolar Disorder (Kathleen R. Merikangas and Tracy L. Peters). 7 Suicide and Bipolar Disorder (Zoltan Rihmer and Jan Fawcett). 8 Neurocognition in Bipolar Disorder (Ivan J. Torres and Gin S. Malhi). 9 The Genius-Insanity Debate: Focus on Bipolarity, Temperament, Creativity and Leadership (Hagop S. Akiskal and Kareen K. Akiskal). 10 Economics of Bipolar Disorder (R. Sabes-Figuera, D. Razzouk and Paul E. McCrone). 11 An Introduction to the Neurobiology of Bipolar Illness Onset, Recurrence and Progression (Robert M. Post and Marcia Kauer-Sant.Anna). 12 Genetics of Bipolar Disorder (Falk W. Lohoff and Wade H. Berrettini). 13 Structural Brain Imaging in Bipolar Disorder (Paolo Brambilla and Jair C. Soares). 14 Functional Magnetic Resonance Imaging, Diffusion Tensor Imaging, and Magnetic Resonance Spectroscopy in Bipolar Disorder (In Kyoon Lyoo and Perry F. Renshaw). 15 Functional Brain Imaging Studies in Bipolar Disorder: Focus on Cerebral Metabolism and Blood Flow (John O. Brooks III, Po W. Wang and Terence A. Ketter). 16 Neurotransmitter Systems in Bipolar Disorder (Marina Nakic, John H. Krystal and Zubin Bhagwagar). 17 Molecular Biology of Bipolar Disorder (Ana Andreazza, Jun Feng Wang and Trevor Young). 18 Mitochondrial Dysfunction and Oxidative Stress (Tadafumi Kato, Flavio Kapczinski and Michael Berk). 19 Neuroendocrinology of Bipolar Illness (Timothy Dinan and Michael Bauer). 20 Circadian Rhythms and Sleep in Bipolar Disorder (Greg Murray and Allison Harvey). 21 Treatment Adherence in Bipolar Disorder (Jan Scott and Mary Jane Tacchi). 22 Acute Mania (Paul E. Keck, Jr, Susan L. McElroy and John M. Hawkins). 23 Pharmacological Treatment of Bipolar Depression (Allan H. Young and Charles B. Nemeroff). 24 Practical Pharmacological Maintenance Treatment of Bipolar Disorder (Alan C. Swann). 25 Rapid Cycling Bipolar Disorder: Phenomenology and Treatment (Joseph F. Goldberg and Michael Berk). 26 Management of Bipolar II Disorder (Gordon Parker and Terence A. Ketter). 27 Management of Comorbidity in Bipolar Disorder (Ihsan M. Salloum, Luca Pani and Tiffany Cooke). 28 Bipolar Disorder and Safety Monitoring for Clinicians: A Review of the Evidence and the Implications (Chris J. Bushe and Mauricio Tohen). 29 Somatic Treatments for Bipolar Disorder: ECT, VNS and TMS (Mark S. George). 30 Novel Therapeutic Strategies for Bipolar Disorder (Rodrigo Machado-Vieira, Husseini K. Manji and Carlos A. Zarate Jr). 31 Psychoeducation as a Core Element of Psychological Approaches for Bipolar Disorders (Francesc Colom and Lesley Berk). 32 Cognitive-Behavioural Therapy for Bipolar Disorder (Sagar V. Parikh and Jan Scott). 33 Interpersonal and Social Rhythm Therapy for Bipolar Disorder (Holly A. Swartz, Ellen Frank, Laura E. Zajac and David J. Kupfer). 34 Family Therapy Approaches to Bipolar Disorder (David J. Miklowitz). 35 Collaborative Care for Bipolar Disorder (Amy M. Kilbourne, David E. Goodrich and Mark S. Bauer). 36 Bipolar Disorder in Women (Benicio N. Frey, Karine A. Macritchie, Claudio N. Soares and Meir Steiner). 37 Phenomenology and Treatment of Bipolar I Disorder in Children: A Critical Review (Gabrielle A. Carlson and Elizabeth B. Weller). 38 Bipolar Disorder in the Elderly (Martha Sajatovic and Lars Vedel Kessing). Index.

Read more less

Book SynopsisBipolar Psychopharmacotherapy covers both pharmacotherapy and the role of psychotherapy, psychoeducation, and social approaches to provide a broad integrative philosophy of care for bipolar patients.Trade Review“This is an interesting, easy to read, and informative book that presents research treatment outcome data to support treatment direction and choices. Anything one needs to know about bipolar disorder is thoroughly covered. This is a book psychiatrists, psychologists, social workers, nurses, doctors of pharmacy, residents, students in medical training programs, patients, and their families may find helpful in understanding the complexities and available treatment choices and their limitations. With the continuing research, this update is justified, and a third edition will soon be needed to keep current.” (Doddy's, 20 April 2012) Table of ContentsList of Contributors. Preface to the Second Edition. Chapter 1 The scope of bipolar disorders (Hagop S. Akiskal). 1.1 Diagnostic and public health aspects. 1.2 Psychological and social aspects. Chapter 2 Lithium treatment: Focus on long-term prophylaxis (Paul Grof and Mogens Schou). 2.1 Introduction. 2.2 Cade's pioneering study. 2.3 Discovery of the prophylactic action of lithium. 2.4 Practical issues. 2.5 Are new and better prophylactic agents about to oust lithium? 2.6 Combination treatment. 2.7 Prophylaxis in recurrent depressive disorder. 2.8 The effect of lithium on the patients' suicidal behavior. 2.9 Benefits of prophylactic lithium treatment. 2.10 Conclusion. Chapter 3 Valproate: Clinical pharmacological profile (Charles L. Bowden and Vivek Singh). 3.1 Historical background. 3.2 Structure–activity relationships. 3.3 Pharmacodynamic properties. 3.4 Pharmacokinetics and metabolic clearance. 3.5 Serum concentration and efficacy. 3.6 Efficacy and indications. 3.7 Efficacy in bipolar disorder. 3.8 Combination strategy in acute mania. 3.9 Prophylaxis in bipolar disorder. 3.10 Treatment of bipolar depression. 3.11 Valproate in treatment of bipolar disorder in children and adolescents. 3.12 Use in bipolar illness comorbid with alcoholism. 3.13 Bipolar disorder comorbid with ADHD. 3.14 Bipolar disorder comorbid with borderline personality disorder. 3.15 Adverse effects. 3.16 Comparative adverse effects. 3.17 Adverse effects in combination therapy, compared with monotherapy. 3.18 Adverse effects by bodily system. 3.19 Summary. Chapter 4 Pharmacological profile and clinical utility of lamotrigine in mood disorders (Marc L.M. van der Loos, Joseph R. Calabrese, Willem A. Nolen and David J. Muzina). 4.1 Introduction. 4.2 Clinical pharmacology of lamotrigine. 4.3 Lamotrigine and mood disorders. 4.4 Safety. 4.5 Clinical applications for lamotrigine in mood disorders. 4.6 Summary. Chapter 5 Carbamazepine and other anticonvulsants (Heinz Grunze). 5.1 Introduction. 5.2 Conclusions. Chapter 6 Olanzapine in treatment for bipolar disorder (Mauricio Tohen, Giedra Campbell and Juan-Carlos Gomez). 6.1 Introduction. 6.2 Rationale in the clinical trial development of olanzapine. 6.3 Efficacy in the treatment of acute mania. 6.4 Efficacy in the treatment of bipolar depression. 6.5 Efficacy in bipolar maintenance/relapse prevention. 6.6 Safety and tolerability. 6.7 Summary. Chapter 7 Haloperidol and other first generation antipsychotics in mania (John Cookson). 7.1 Introduction. 7.2 Acute tranquillization in mania. 7.3 Sedation is not required for antipsychotics to improve mania. 7.4 Chlorpromazine in mania. 7.5 Haloperidol in mania. 7.6 Hormone changes and mechanisms of antimanic effects of antipsychotics. 7.7 Antipsychotics as mood stabilizers. 7.8 Placebo-controlled studies in mania. 7.9 Recent comparative trials without placebo. 7.10 Pharmacoeconomics. 7.11 Conclusions. Chapter 8 Clinical utility of clozapine in bipolar disorder (V.E. Cosgrove, J.S. Seo, H. Yang and Trisha Suppes). 8.1 Introduction. 8.2 History. 8.3 Clinical pharmacology of clozapine. 8.4 Clozapine in bipolar disorders. 8.5 Effective pharmacotherapy for bipolar disorder? 8.6 Case studies. Chapter 9 Risperidone and paliperidone in the treatment of bipolar disorder (L. Ivo Caers and Joris Berwaerts). 9.1 Introduction. 9.2 Oral risperidone in bipolar mania. 9.3 Paliperidone extended release (ER) in bipolar mania. 9.4 Risperidone long-acting injectable (LAI) in the maintenance treatment of bipolar disorder. 9.5 Elements of special interest. 9.6 Summary and conclusions. Chapter 10 Quetiapine in bipolar disorder (Mauricio Kunz, Svante Nyberg and Lakshmi N. Yatham). 10.1 Introduction. 10.2 Pharmacology. 10.3 Quetiapine in the treatment of acute mania. 10.4 Quetiapine in the treatment of acute bipolar depression. 10.5 Quetiapine in the maintenance treatment of bipolar disorder. 10.6 Safety and tolerability of quetiapine. 10.7 Summary. Chapter 11 Ziprasidone in the treatment of bipolar disorder (Thomas L. Schwartz, Stephen M. Stahl, Elizabeth Pappadopulos and Onur N. Karayal). 11.1 Introduction. 11.2 Ziprasidone and its proposed mechanism of action. 11.3 Ziprasidone in treatment guidelines. 11.4 Overview of ziprasidone efficacy from clinical trial data. 11.5 Acute manic/mixed episodes. 11.6 Acute depressive episodes. 11.7 Long term maintenance treatment of bipolar disorder. 11.8 Practical guidance on the use of ziprasidone in bipolar disorder. 11.9 Safety and tolerability. 11.10 Treatment of special populations. 11.11 Summary and conclusions. Chapter 12 Aripiprazole in bipolar disorder (Alessandra Nivoli and Eduard Vieta). 12.1 Aripiprazole and its mode of action. 12.2 Aripiprazole in treatment guidelines. 12.3 Aripiprazole efficacy from clinical trial data. 12.4 Aripiprazole safety and tolerability. 12.5 Treatment of special populations. 12.6 Pharmacogenetics of aripiprazole. Chapter 13 Asenapine in bipolar disorder (Roger S. McIntyre). 13.1 Introduction. 13.2 Pharmacology. 13.3 Human pharmacokinetics. 13.4 Asenapine: Efficacy in bipolar mania and mixed states. 13.5 Asenapine: Efficacy and tolerability during extension treatment. 13.6 Summary and conclusion. Chapter 14 Complex combination therapy for long-term stability in bipolar disorder (Robert M. Post). 14.1 Introduction. 14.2 Rationale for complex combination therapy in bipolar illness. 14.3 Principles of building an effective therapeutic regimen. 14.4 Conclusions. Chapter 15 The role of antidepressants in bipolar disorder (Boghos I. Yerevanian). 15.1 Introduction. 15.2 Tricyclic antidepressants. 15.3 MAO inhibitors. 15.4 SSRIs. 15.5 SNRIs: Venlafaxine, mirtazapine, duloxetine. 15.6 Bupropion. 15.7 Clinical and research implications. Chapter 16 Bipolarity in women: Therapeutic issues (Susan L. McElroy, Lesley M. Arnold and Lori L. Altshuler). 16.1 Introduction. 16.2 Epidemiology and gender distribution of the bipolar spectrum. 16.3 Gender differences in phenomenology. 16.4 Gender differences in course and outcome. 16.5 Gender differences in comorbidity. 16.6 Bipolar disorder and the reproductive cycle. 16.7 Treatment of bipolar disorder in females. 16.8 Summary. Chapter 17 Pediatric bipolar disorder: The promise of psychopharmacotherapy (Tiffany Thomas and Robert L. Findling). 17.1 Introduction. 17.2 Lithium. 17.3 Anticonvulsants. 17.4 Antipsychotics. 17.5 Conclusion. Chapter 18 Treatment of bipolar disorder in old age (Kenneth I. Shulman, Nathan Herrmann and Martha Sajatovic). 18.1 Treatment of bipolar disorder in old age. 18.2 Management of bipolar disorder in the elderly. 18.3 Treatment of bipolar depression in older adults. 18.4 The future. Chapter 19 Diagnosis and treatment of mixed states (Alan C. Swann). 19.1 What is a mixed state? 19.2 General considerations for treatment strategies in mixed states. 19.3 Treating mania in mixed states. 19.4 Treating depression in mixed states. 19.5 Nonpharmacological treatments. 19.6 An Integrated model for treating mixed states. 19.7 Conclusions. Chapter 20 Rapid cycling of bipolar patients (Athanasios Koukopoulos, G. Serra, F. Zazzara, A. E. Koukopoulos and G. Sani). 20.1 Introduction. 20.2 Epidemiological data. 20.3 Spontaneous and induced rapid cycling. 20.4 Temperament and rapid cycling. 20.5 Course. 20.6 Clinical picture of rapid cycling. 20.7 Neurobiology of rapid cycling bipolar disorder: The role of dopamine D2 receptors, sensitization. 20.8 Treatment. 20.9 Discussion. Chapter 21 Novel therapeutic approaches for treating bipolar disorder (Rodrigo Machado-Vieira, Ioline Henter, Jacqueline Baumann, David Latov, Cristina Wheeler-Castillo and Carlos A. Zarate). 21.1 Introduction. 21.2 The dynorphin opioid neuropeptide system. 21.3 The purinergic system. 21.4 The melatonergic system. 21.5 The glutamatergic system. 21.6 The tachykinin neuropeptides system. 21.7 The glucocorticoid system. 21.8 The arachidonic acid (AA) cascade. 21.9 The endocannabinoid system. 21.10 Oxidative stress and bioenergetics. 21.11 The intracellular signaling pathways. 21.12 Final remarks. Chapter 22 The pivotal role of psycho-education in the long-term treatment of bipolar disorder (Francesc Colom and Andrea Murru). 22.1 Introduction. 22.2 On the need for psycho-education. 22.3 The five ingredients of psycho-education. 22.4 Substance misuse avoidance. 22.5 Early warning signs – detection. 22.6 Lifestyle regularity (and miscellanea). 22.7 Psycho-education with the family. 22.8 Long-term follow-up. 22.9 The future. 22.10 Funding sources and acknowledgments. Chapter 23 The role of treatment setting in the pharmacotherapy of bipolar disorder (Jean-Michel Azorin). 23.1 Implementation of drug treatment according to phase and severity of illness. 23.2 Pretreatment evaluation and monitoring of pharmacotherapy. 23.3 Drug response and treatment setting. 23.4 From efficacy to efficiency of pharmacotherapy in bipolar illness. Chapter 24 Pharmacological prevention of suicide in bipolar patients (Zoltan Rihmer). 24.1 Introduction. 24.2 Mood disorders and suicidal behavior. 24.3 Risk of suicidal behavior in bipolar disorders. 24.4 Suicide prevention in bipolar disorders. Chapter 25 Overview of principles of caring for bipolar patients (Hagop S. Akiskal and Kareen K. Akiskal). 25.1 Introduction. 25.2 The major players in bipolar disorder. 25.3 Principles of caring. 25.4 Special considerations for hypomanic and cyclothymic patients. 25.5 Conclusion. References. Index.

Read more less

Book SynopsisGenetic and Evolutionary Computation: Medical Applications provides an overview of the range of GEC techniques being applied to medicine and healthcare in a context that is relevant not only for existing GEC practitioners but also those from other disciplines, particularly health professionals. There is rapidly increasing interest in applying evolutionary computation to problems in medicine, but to date no text that introduces evolutionary computation in a medical context. By explaining the basic introductory theory, typical application areas and detailed implementation in one coherent volume, this book will appeal to a wide audience from software developers to medical scientists. Centred around a set of nine case studies on the application of GEC to different areas of medicine, the book offers an overview of applications of GEC to medicine, describes applications in which GEC is used to analyse medical images and data sets, derive advanced models, and suggest diagnoses and Table of ContentsAbout the Editors. List of Contributors. 1 Introduction. 2 Evolutionary Computation: A Brief Overview (Stefano Cagnoni and Leonardo Vanneschi). 2.1 Introduction. 2.2 Evolutionary Computation Paradigms. 2.2.1 Genetic Algorithms. 2.2.2 Evolution Strategies. 2.2.3 Evolutionary Programming. 2.2.4 Genetic Programming. 2.2.5 Other Evolutionary Techniques. 2.2.6 Theory of Evolutionary Algorithms. 2.3 Conclusions. 3 A Review of Medical Applications of Genetic and Evolutionary Computation (Stephen L. Smith). 3.1 Medical Imaging and Signal Processing. 3.1.1 Overview. 3.1.2 Image Segmentation. 3.1.3 Image Registration, Reconstruction and Correction. 3.1.4 Other Applications. 3.2 Data Mining Medical Data and Patient Records. 3.3 Clinical Expert Systems and Knowledge-based Systems. 3.4 Modelling and Simulation of Medical Processes. 3.5 Clinical Diagnosis and Therapy. 4 Applications of GEC in Medical Imaging. 4.1 Evolutionary Deformable Models for Medical Image Segmentation: A Genetic Algorithm Approach to Optimizing Learned, Intuitive, and Localized Medial-based Shape Deformation (Chris McIntosh and Ghassan Hamarneh). 4.1.1 Introduction. 4.1.1.1 Statistically Constrained Localized and Intuitive Deformations. 4.1.1.2 Genetic Algorithms. 4.1.2 Methods. 4.1.2.1 Population Representation. 4.1.2.2 Encoding the Weights for GAs. 4.1.2.3 Mutations and Crossovers. 4.1.2.4 Calculating the Fitness of Members of the GA Population. 4.1.3 Results. 4.1.4 Conclusions. 4.2 Feature Selection for the Classification of Microcalcifications in Digital Mammograms using Genetic Algorithms, Sequential Search and Class Separability (Santiago E. Conant-Pablos, Rolando R. Hernández-Cisneros, and Hugo Terashima-Marín). 4.2.1 Introduction. 4.2.2 Methodology. 4.2.2.1 Pre-processing. 4.2.2.2 Detection of Potential Microcalcifications (Signals). 4.2.2.3 Classification of Signals into Microcalcifications. 4.2.2.4 Detection of Microcalcification Clusters. 4.2.2.5 Classification of Microcalcification Clusters into Benign and Malignant. 4.2.3 Experiments and Results. 4.2.3.1 From Pre-processing to Signal Extraction. 4.2.3.2 Classification of Signals into Microcalcifications. 4.2.3.3 Microcalcification Clusters Detection and Classification. 4.2.4 Conclusions and Future Work. 4.3 Hybrid Detection of Features within the Retinal Fundus using a Genetic Algorithm (Vitoantonio Bevilacqua, Lucia Cariello, Simona Cambo, Domenico Daleno, and Giuseppe Mastronardi). 4.3.1 Introduction. 4.3.2 Acquisition and Processing of Retinal Fundus Images. 4.3.2.1 Retinal Image Acquisition. 4.3.2.2 Image Processing. 4.3.3 Previous Work. 4.3.4 Implementation. 4.3.4.1 Vasculature Extraction. 4.3.4.2 A Genetic Algorithm for Edge Extraction. 4.3.4.3 Skeletonization Process. 4.3.4.4 Experimental Results. 5 New Analysis of Medical Data Sets using GEC. 5.1 Analysis and Classification ofMammography Reports using Maximum Variation Sampling (Robert M. Patton, Barbara G. Beckerman, and Thomas E. Potok). 5.1.1 Introduction. 5.1.2 Background. 5.1.3 Related Works. 5.1.4 Maximum Variation Sampling. 5.1.5 Data. 5.1.6 Tests. 5.1.7 Results & Discussion. 5.1.8 Summary. 5.2 An Interactive Search for Rules in Medical Data using Multiobjective Evolutionary Algorithms (Daniela Zaharie, D. Lungeanu, and Flavia Zamfirache). 5.2.1 Medical Data Mining. 5.2.2 Measures for Evaluating the Rules Quality. 5.2.2.1 Accuracy Measures. 5.2.2.2 Comprehensibility Measures. 5.2.2.3 Interestingness Measures. 5.2.3 Evolutionary Approaches in Rules Mining. 5.2.4 An Interactive Multiobjective Evolutionary Algorithm for Rules Mining. 5.2.4.1 Rules Encoding. 5.2.4.2 Reproduction Operators. 5.2.4.3 Selection and Archiving. 5.2.4.4 User Guided Evolutionary Search. 5.2.5 Experiments in Medical Rules Mining. 5.2.5.1 Impact of User Interaction. 5.2.6 Conclusions. 5.3 Genetic Programming for Exploring Medical Data using Visual Spaces (Julio J. Valdés, Alan J. Barton, and Robert Orchard). 5.3.1 Introduction. 5.3.2 Visual Spaces. 5.3.2.1 Visual Space Realization. 5.3.2.2 Visual Space Taxonomy. 5.3.2.3 Visual Space Geometries. 5.3.2.4 Visual Space Interpretation Taxonomy. 5.3.2.5 Visual Space Characteristics Examination. 5.3.2.6 Visual Space Mapping Taxonomy. 5.3.2.7 Visual Space Mapping Computation. 5.3.3 Experimental Settings. 5.3.3.1 Implicit Classical Algorithm Settings. 5.3.3.2 Explicit GEP Algorithm Settings. 5.3.4 Medical Examples. 5.3.4.1 Data Space Examples. 5.3.4.2 Semantic Space Examples. 5.3.5 Future Directions. 6 Advanced Modelling, Diagnosis and Treatment using GEC. 6.1 Objective Assessment of Visuo-spatial Ability using Implicit Context Representation Cartesian Genetic Programming (Michael A. Lones and Stephen L. Smith). 6.1.1 Introduction. 6.1.2 Evaluation of Visuo-spatial Ability. 6.1.3 Implicit Context Representation CGP. 6.1.4 Methodology. 6.1.4.1 Data Collection. 6.1.4.2 Evaluation. 6.1.4.3 Parameter Settings. 6.1.5 Results. 6.1.6 Conclusions. 6.2 Towards an Alternative to Magnetic Resonance Imaging for Vocal Tract Shape Measurement using the Principles of Evolution (David M. Howard, Andy M. Tyrrell, and Crispin Cooper). 6.2.1 Introduction. 6.2.2 Oral Tract Shape Evolution. 6.2.3 Recording the Target Vowels. 6.2.4 Evolving Oral Tract Shapes. 6.2.5 Results. 6.2.5.1 Oral Tract Areas. 6.2.5.2 Spectral Comparisons. 6.2.6 Conclusions. 6.3 How Genetic Algorithms can Improve Pacemaker Efficiency (Laurent Dumas and Linda El Alaoui). 6.3.1 Introduction. 6.3.2 Modeling of the Electrical Activity of the Heart. 6.3.3 The Optimization Principles. 6.3.3.1 The Cost Function. 6.3.3.2 The Optimization Algorithm. 6.3.3.3 A New Genetic Algorithm with a Surrogate Model. 6.3.3.4 Results of AGA on Test Functions. 6.3.4 A Simplified Test Case for a Pacemaker Optimization. 6.3.4.1 Description of the Test Case. 6.3.4.2 Numerical Results. 6.3.5 Conclusion. 7 The Future for Genetic and Evolutionary Computation in Medicine: Opportunities, Challenges and Rewards. 7.1 Opportunities. 7.2 Challenges. 7.3 Rewards. 7.4 The Future for Genetic and Evolutionary Computation in Medicine. Appendix: Introductory Books and Useful Links. Index.

Read more less

Book SynopsisThis book is an archival reference for the evolving field of biomaterials and their applications in society, focusing on their composition, properties, characterization, chemistry and applications in bioenergy, chemicals, and novel materials and biomaterials.It has broad appeal due to the recent heightened awareness around bioenergy and biomass as potential replacements for petroleum feedstocks.The book is divided into three parts: cellulose-based biomaterials, chitin and chitosan biomaterials, and hemicelluloses and other polysaccharides. Each chapter addresses a separate biomaterial, discussing its chemical, physical, and biological attributes, and hones in on each compound''sintrinsic tunabilityfor numerous chemical transformations.In the current quest for a green economy and resources, this book will help inspire scientists towardsnovel sources for chemicals, materials, andenergy in the years to come.Table of ContentsForeword vii Preface ix Contributors xi 1 Recent Advances in Cellulose Chemistry 1 Thomas Heinze and Katrin Petzold-Welcke 2 Cellulosic Aerogels 51 Falk Liebner, Emmerich Haimer, Antje Potthast, and Thomas Rosenau 3 Nanocelluloses: Emerging Building Blocks for Renewable Materials 105 Youssef Habibi and Lucian A. Lucia 4 Interactions of Chitosan with Metals for Water Purification 127 Mohammed Rhazi, Abdelouhad Tolaimate, and Youssef Habibi 5 Recent Developments in Chitin and Chitosan Bio-Based Materials Used for Food Preservation 143 Véronique Coma 6 Chitin and Chitosan as Biomaterial Building Blocks 177 JoséF. Louvier-Hernández and Ram B. Gupta 7 Chitosan Derivatives for Bioadhesive/Hemostatic Applications: Chemical and Biological Aspects 199 Mai Yamazaki and Samuel M. Hudson 8 Chitin Nanofibers as Building Blocks for Advanced Materials 227 Youssef Habibi and Lucian A. Lucia 9 Electrical Conductivity and Polysaccharides 247 Axel Rußler and Thomas Rosenau 10 Polysaccharide-Based Porous Materials 271 Peter S. Shuttleworth, Avtar Matharu, and James H. Clark 11 Starch-Based Bionanocomposites: Processing and Properties 287 Visakh P. M., Aji P. Mathew, Kristiina Oksman, and Sabu Thomas 12 Starch-Based Sustainable Materials 307 Luc Avérous 13 The Potential of Xylans as Biomaterial Resources 331 Anna Ebringerova 14 Micro- and Nanoparticles from Hemicelluloses 367 Emmerich Haimer, Falk Liebner, Antje Potthast, and Thomas Rosenau 15 Nonxylan Hemicelluloses as a Source of Renewable Materials 387 David Plackett and Natanya Hansen Index 409

Read more less

Book Synopsis* The first single source work to deal with the two primary radiologic modalities in diagnosing and treating benign and malignant diseases of the liver, presented with clearly laid out MRI and CT correlations. Developed by an editor team led by one of the world s leading authorities in abdominal imaging, Richard C. Semelka MD.Table of ContentsList of Contributors, vii Preface, ix 1 The Cross-Sectional Anatomy of the Liver and Normal Variations1Ersan Altun, Mohamed El-Azzazi, and Richard C. Semelka 2 The Cross-Sectional Imaging Techniques and Diagnostic Approach 15Ersan Altun and Richard C. Semelka 3 Safety of MRI and CT 63Ersan Altun and Richard C. Semelka 4 Cystic Diseases of the Liver 73Ersan Altun, Mohamed, El-Azzazi, Richard C. Semelka, and Miguel Ramalho 5 Benign Solid Liver Lesions 101Ersan Altun, Mohamed El-Azzazi, Richard C. Semelka, and Mamdoh AlObaidy 6 Liver Metastases 137Ersan Altun, Mohamed El-Azzazi, Richard C. Semelka, and Miguel Ramalho 7 Hepatocellular Carcinoma 161Ersan Altun, Mohamed El-Azzazi, Richard C. Semelka, and Mamdoh AlObaidy 8 Rare Primary and Secondary Tumors of the Liver 181Ersan Altun, Mohamed El-Azzazi, and Richard C. Semelka 9 Cholangiocarcinoma 193Ersan Altun, Mohamed El-Azzazi, Richard C. Semelka, and Miguel Ramalho 10 Infectious Diseases of the Liver, 201Ersan Altun, Mohamed El-Azzazi, and Richard C. Semelka 11 Chronic Hepatitis and Liver Cirrhosis 219Ersan Altun, Mohamed El-Azzazi, Richard C. Semelka, and Mamdoh AlObaidy 12 Hepatic Fat and Iron Deposition 241Ersan Altun, Mohamed El-Azzazi, and Richard C. Semelka 13 Inflammatory Liver Diseases 255Ersan Altun, Mohamed El-Azzazi, and Richard C. Semelka 14 Vascular Disorders of the Liver 267Ersan Altun, Mohamed El-Azzazi, and Richard C. Semelka 15 Post-treatment Changes in the Liver 285Ersan Altun, Mohamed El-Azzazi, and Richard C. Semelka 16 Liver Trauma 301Ersan Altun, Mohamed El-Azzazi, and Richard C. Semelka Index 305

Read more less

Book SynopsisThis volume contains information on assessing, diagnosing and treatment planning for the range of psychiatric and psychologic problems children and adolescents may experience during their development. It includes in-depth coverage of these issues and also includes decision trees for some topics, which are brief flowcharts for practitioners to follow when assessing patients for suspected problems.Table of ContentsCLINICAL ASSESSMENT. Types and Goals of Clinical Assessment (M. Dulcan). Classification Systems and Nosology (T. Achenbach). Vulnerabilities, Risk Factors, Protective Factors, and Resilience (N. Grant). Communicating with Children (J. Demb & S. Harrison). Communicating with Adolescents (R. Hendren & B. Sarvet). Engaging Parents in Clinical Processes (S. Brown). Clinical Use of Interpreters (W. Arroyo). Experimental Concepts in Clinical Assessment (K. Wells). The Ethics of Consent and Confidentiality in Clinical Practice (G. Leong & S. Eth). DECISION TREES FOR A SAMPLING OF PRESENTING PROBLEMS. Disruptive Behavior (P. Tolan & M. Kruesi). Shyness and Fearfulness (R. Mattison). Unhappiness (J. Bemporad & S. Gabel). Difficulty with Academic Performance (L. Silver & R. Ostrander). Sleep Difficulty (M. Naylor). Appetite Disturbances: Anorexia and Hyperphagia (H. Steiner). Substance Abuse (S. Jaffe & J. Gould). Suicidal Behavior (C. Pfeffer). Bizarre, Odd, and Eccentric Behavior (P. Tanguay). Enuresis (G. Fritz & R. Rockney). Encopresis (R. Rockney & O. Hagino). School Refusal (R. Klein). Lying (E. Bleiberg & S. Atkinson). Stealing (E. Bleiberg & S. Atkinson). Temper Tantrums (S. Brown & H. Reid). Speech and Language Disorders (L. Zukerman & D. Cantwell). Language Delay (J. Fischel & G. Whitehurst). Accident-Proneness (M. Sokol & N. Gray). No Friends (A. Clarkin). Runaway Behavior (J. Sargent). Involuntary Movements (B. Peterson). INITIATING ASSESSMENT. The Initial Encounter (R. King). Assessment of Dangerousness (J. Jankowski). CLINICAL HISTORY. Psychiatric History (M. Dulcan). Genetic, Prenatal, and Delivery History (L. Lotspeich). Neonatal and Infancy History (K. Minde). Preschool History (K. Minde). History of School-Age Children (R. King). Puberty and Adolescence (C. Sylvester & S. Weissman). Temperament and Personality (R. Seifer). Speech, Language, and Communication (C. Baltaxe). Health History (H. Steiner). Nutrition Assessment (P. Novak & M. Baer). Assessment of Gender and Sexual Development in Children (S. Coates & S. Wolfe. Assessment of Sexual and Gender Development in Adolescents (S. Bradley). Assessment of Conscience Development (C. Keith). Assessment of Cognitive Processes (D. Siegel). Social Communication (P. Tanguay). Family History (A. Josephson & F. Moncher). Peer and Adult Relationships (A. Clarkin). Socioeconomic Factors (E. Messinger). Legal Factors (D. Cornell). Cultural and Religious Issues (P. Muehrer). Occupational Assessment (S. Haiman & S. Greene). Vocational Assessment (E. Lang). Educational Issues (R. Ostrander & L. Silver). Trauma History (L. Terr). Disabilities History (H. Sachs). CLINICAL OBSERVATION. Observation, Interview, and Mental Status Assessment (OIM): Parent(s) (L. Arnold & P. Jensen). Observation, Interview, and Mental Status Assessment (OIM): Infants and Preschool Children (K. Minde). Observation, Interview, and Mental Status Assessment (OIM): School-Aged Children (R. King). Observation, Interview, and Mental Status Assessment (OIM): Puberty, Adolescents, and Young Adults (S. Weissman & C. Sylvester). Observation, Interview, and Mental Status Assessment (OIM): Family Unit and Subunits (A. Josephson & F. Moncher). The Home Visit (E. Messinger). The School Visit (M. Gordon). Observation, Interview, and Mental Status Assessment (OIM): Unwilling or Resistant (M. Blotcky). Observation, Interview, and Mental Status Assessment (ODM): Culturally Different from Clincian (S. Silverman & J. McDermott). Observation, Interview, and Mental Status Assessment (OIM): Possibly Abused (S. Kaplan). Observation, Interview, and Mental Status Assessment (OIM): Possibly Substance Abusing (J. Gould & S. Jaffe). Observation, Interview, and Mental Status Assessment (OIM): Slow Learning (L. Silver & R. Ostrander). Observation, Interview, and Mental Status Assessment (OIM): Physically ILL (L. Cahen & M. Jellinek). Observation, Interview, and Mental Status Assessment (OIM): Traumatized (L. Terr). Observation, Interview, and Mental Status Assessment (OIM): Violent (E. Pittel). Observation, Interview, and Mental Status Assessment (OIM): Disabled (H. Sachs). Observation, Interview, and Mental Status Assessment (OIM): Competence to Testify (K. Saywitz). Observation, Interview, and Mental Status Assessment (OIM): Competence for Independent Decision Making (P. Ash, et al.). Observation, Interview, and Mental Status Assessment (OIM): Pregnant Adolescent and Teen Parent (L. Ware). Observation, Interview, and Mental Status Assessment (OIM): Adopted (A. Sorosky & B. Sorosky). Observation, Interview, and Mental Status Assessment (OIM): Single-Parent Homes (J. Larrieu & C. Zeanah). Observation, Interview, and Mental Status Assessment (OIM): Divorce (N. Kalter). Observation, Interview, and Mental Status Assessment (OIM): Homosexual (R. Pleak & D. Anderson). Observation, Interview, and Mental Status Assessment (OIM): Cult Involvement (L. West). Physical Examination (J. McConville & B. McConville). Neurological Examination (J. Bregman). Behavioral Assessment (D. Goldston & K. Kirkhart). Psychodynamic Assessment (D. Berland). Rating Scales (J. Goldman & J. Rodrigue). Psychological Testing (J. Rodrigue & J. Goldman). Structured Interviews (J. Young, et al.). Laboratory Testing (J. Levitt & J. McCracken). Genetic Studies (L. Lotspeich). Speech, Language, and Hearing (C. Baltaxe). Brian Imaging (M. Ernst & L. Hertz-Pannier). Electrophysicological Studies (S. Pliszka). Computers and Assessment (M. Huang & N. Alessi). CONCLUDING THE ASSESSMENT PROCESS. Clincial Formulation (B. Nurcombe). Clinical Decision Making (B. Nurcombe). Intervention Strategy Planning (B. Nurcombe). Interpretive Interview with Children and Adolescents and their Parent(s) (L. Arnold & P. Jensen). Report Preparation (B. Nurcombe). Epilogue: The Paths to the Bright Future of Clinical Child/Adolescent Psychiatry (CAP) (S. Harrison). Indexes.

Read more less

Book SynopsisBuprenorphine: Combatting Drug Abuse with a Unique Opioid Editors: Alan Cowan and John W. Lewis Scientists involved in the study of opioid pharmacology and drug abuse have long included among their goals the development of effective analgesics with reduced potential for abuse and dependence, and the development of effective pharmacological agents for the treatment of opioid abuse and dependence. Buprenorphine appears to have made an important scientific and clinical contribution on both of these fronts. In this timely volume, international experts describe the unusual chemical and biological characteristics which make this agent unique, from the opiate receptor, through animal pharmacology, to clinical uses, culminating in a discussion of the use of buprenorphine as a medication in the treatment of opioid abuse. Buprenorphine holds great promise as a significant addition to the therapeutic menu available to drug abuse therapists. Buprenorphine: CombaTable of ContentsPartial table of contents: CHEMISTRY. Buprenorphine-Medicinal Chemistry (J. Lewis). PRECLINICAL PHARMACOLOGY. Update on the General Pharmacology of Buprenorphine (A. Cowan). ASSAY, METABOLISM, AND PHARMACOKINETICS. Analysis (R. Moore). CLINICAL PHARMACOLOGY AND EVALUATION. Buprenorphine in Psychiatric Disorders (D. Nutt, et al.). STUDIES RELATING TO TREATMENT OF SUBSTANCE ABUSE. Detoxification and Induction Onto Naltrexone (M. Rosen & T. Kosten). PERSPECTIVE. Buprenorphine: What Interests the National Institute on Drug Abuse? (D. Segal & C. Schuster). Index.

Read more less

Book Synopsis* Presents complex material in an easy to understand progression of ideas. * Illustrates principles by example problems taken from physiology and medicine or design problems involving biomedical devices.Table of ContentsPreface xvi Guidance to Instructors xvii Methods for Solving Model Equations xix Acknowledgments xx About the Companion Website xxi Part I Introduction 1 1 Biological Structure and Function 3 1.1 Cell Energy Related to Whole-Body Function 4 1.2 Tissue and Organ Systems 8 1.3 Cell Structure and Energy Metabolism 16 2 Modeling Concepts for Biological Mass Transport 21 2.1 Representation of Biological Media 21 2.2 Mechanisms of Mass Transport 25 2.3 Formulation of Material Balances 30 2.4 Spatially Lumped and Distributed Models 32 References 39 Part II Thermodynamics of Biomedical Processes 41 3 Basics of Equilibrium Thermodynamics 43 3.1 Thermodynamic Systems and States 43 3.2 Heat, Work, and the First Law 44 3.3 Enthalpy and Heat Effects 45 3.4 Entropy and the Second Law 46 3.5 Gibbs Free Energy and Equilibrium 46 3.6 Properties of the Chemical Potential 51 References 53 4 Interfacial and Membrane Equilibria 54 4.1 Equilibrium Criterion 54 4.2 Interfacial Equilibria 56 4.3 Membrane Equilibria 62 4.4 Electrical Double Layer 71 References 75 5 Chemical Reaction Equilibrium 76 5.1 Equilibrium Criterion 76 5.2 Equilibrium Coefficients 78 5.3 Acid Dissociation 80 5.4 Ligand–Receptor Binding 83 5.5 Equilibrium Models of Blood Gas Content 90 References 101 Part III Fundamentals of Rate Processes 103 6 Nonequilibrium Thermodynamics and Transport Rates 105 6.1 Transport Velocities and Fluxes 105 6.2 Stefan–Maxwell Equation 109 6.3 Diffusion of Uncharged Substances 111 6.4 Diffusion of Electrolytes 116 6.5 Transport across Membranes 117 References 123 7 Mechanisms and Models of Diffusion 124 7.1 Transport Rates in Homogeneous Materials 125 7.2 Diffusion Coefficients in Gases 125 7.3 Diffusion Coefficients in Liquids 128 7.4 Transport in Porous Media Models of Tissue 134 7.5 Transport in Suspension Models of Tissue 144 References 151 8 Chemical Reaction Rates 152 8.1 General Kinetic Models 152 8.2 Basis of Reaction Rate Equations 154 8.3 Multi-Step Reactions 158 8.4 Ligand–Receptor Kinetics 161 8.5 Enzyme Kinetics 166 8.6 Urea Cycle as a Reaction Network 173 References 178 Part IV Transport Models in Fluids and Membranes 179 9 Unidirectional Transport 181 9.1 Unidirectional Transport Equations 181 9.2 Steady-State Diffusion 186 9.3 Diffusion with Parallel Convection 191 9.4 Diffusion with Chemical Reaction 194 9.5 Unsteady-State Diffusion 201 References 203 10 Membrane Transport I: Convection and Diffusion Processes 204 10.1 Ordinary Diffusion 204 10.2 Diffusion with Parallel Convection 211 10.3 Cell Membrane Channels 216 References 223 11 Membrane Transport II: Carrier-Mediated Processes 224 11.1 Facilitated Transport of a Single Substance 224 11.2 Cotransport of Two Substrates 227 11.3 Simulation of Tracer Experiments 230 11.4 Primary Active Transport 237 11.5 Electrical Effects on Ion Transport 242 References 244 12 Mass Transfer Coefficients and Chemical Separation Devices 245 12.1 Transport Through a Single Phase 245 12.2 Transport Through Multiple Phases 256 12.3 Design and Performance of Separation Devices 265 References 279 Part V Multidimensional Processes of Molecules and Cells 281 13 Fluid Mechanics I: Basic Concepts 283 13.2 Mechanical Properties and Rheology of Fluids 289 13.3 Model Formulation and Scaling of Fluid Flow 293 13.4 Steady Flow Through A Tube 299 References 306 14 Fluid Mechanics II: Complex Flows 307 14.1 Boundary Layer Flows 307 14.2 Creeping Flow Through a Leaky Tube 319 14.3 Periodic Flow Along a Tube 323 Reference 329 15 Mass Transport I: Basic Concepts and Nonreacting Systems 330 15.1 Three-Dimensional Mass Balances 330 15.2 Special Cases 332 15.3 One-Dimensional Transport Equations 334 15.4 Model Formulation and Scaling of Mass Transport 339 15.5 Diffusion and Convection in Nonreacting Systems 344 References 357 16 Mass Transport II: Chemical Reacting Systems 358 16.1 Single-Phase Processes 358 16.2 Multiphase Processes 368 16.3 Processes with Interfacial Reaction 380 References 387 17 Cell Population Dynamics 388 17.1 Cell Number Balances 388 17.2 Cell Transport and Fate Processes 389 17.3 Single Cell Population Dynamics 394 17.4 Multiple Cell Population Dynamics 399 Reference 409 Part VI Compartmental Modeling 411 18 Compartment Models I: Basic Concepts and Tracer Analysis 413 18.1 Compartmental Modeling Concepts 413 18.2 Multiple-Compartment Models 421 18.3 Nonideal Inputs and Moment Analysis 430 Reference 438 19 Compartment Models II: Analysis of Physiological Systems 439 19.1 Open-Loop Models 439 19.1.1 Multipool Model of Glucose Metabolism 439 19.2 Models with Feedback and Recirculation 452 References 466 Part VII Advanced Biomedical Applications 467 20 Therapies for Tissue and Organ Dysfunction 469 20.1 Dynamics of Urea Clearance in a Patient During Hemodialysis 469 20.2 Hemodialyzer Performance with Varying Filtration 474 20.3 Gas Exchange in an Intravascular Lung Device 480 20.4 Separation of Blood Components by Apheresis 486 20.5 Epidermal Regeneration in Tissue-Engineered Skin 490 References 497 21 Drug Release, Delivery, and Distribution 498 21.1 Drug Release From an Agglomerated Tablet 498 21.2 Drug Release From an Osmotic Pump Device 504 21.3 Intestinal Drug Transport 509 21.4 Drug Distribution in Ablated Tissues 515 21.5 Intracranial Drug Delivery and Distribution 520 21.6 Whole-Body Methotrexate Distribution 526 References 534 22 Diagnostics and Sensing 535 22.1 Chemical Monitoring of Tissue by Microdialysis 535 22.2 Dual-Electrode Measurement of Blood Flow and Oxygen 541 22.3 Detection of Ethanol in Blood from Exhaled Gas 546 22.4 Oxygen Uptake and Utilization in Exercising Muscle 552 22.5 Tracer Analysis with Pet Imaging 562 22.6 Cancer Cell Migration with Cell–Cell Interaction 569 References 576 Appendix A Units and Property Data 577 A.1 American National Standard for SI Units 577 A.2 Definitions of Concentration 579 A.3 Thermodynamic Properties 580 A.4 Transport Properties 583 References 586 Appendix B Representing Transport Processes in Complex Systems 587 B.1 Vector and Tensor Operations 587 B.2 Nonequilibrium Thermodynamics 592 B.3 Spatially Averaged Balances for Heterogeneous Tissue 596 B.4 Tables for Fluid Motion in Common Coordinate Systems 602 References 604 Appendix C Mathematical Methods 605 C.1 Dimensionless Forms and Scaling 605 C.2 Inversion of Square Matrices 608 C.3 Initial-value Problems 609 C.4 Laplace Transforms 613 C.5 Alternative Representation of a Point Source 614 C.6 Similarity Transform of a Partial Differential Equation 615 Nomenclature 619 Index 624

Read more less

Book SynopsisCancer Epigenetics: Biomolecular Therapeutics in Human Cancer is the only resource to focus on biomolecular approaches to cancer therapy. Its presentation of the latest research in cancer biology reflects the interdisciplinary nature of the field and aims to facilitate collaboration between the basic, translational, and clinical sciences.Trade Review“In summary, this book provides a useful in-depth review of the molecular mechanisms which underpin epigenetic processes, their clinical linkage to cancer, particularly paediatric indications, and the therapeutic potential of targeting epigenetic mechanisms. It is of value to those working in, or entering, this complex and fast-moving field and will be most accessible to those with a biological background and interest.” (ChemMedChem, 1 July 2013)Table of ContentsContributors. Preface. SECTION I: EPIGENETICS AND CELL CYCLE. 1 Epigenetic Modulation of Cell Cycle: An Overview (Micaela Montanari, Antonio Giordano, Marcella Cintorino, and Marcella Macaluso). SECTION II: EPIGENETICS AND CELL DEVELOPMENT, SENESCENCE AND DIFFERENTIATION. 2 Epigenetics in Skeletal Muscle Development (Cristina Giacinti and Antonio Giordano). 3 Epigenetic Control in Cellular Senescence (Heike Helmbold, Wolfgang Deppert, and Wolfgang Bohn). 4 Epigenetic Modulation in Cell Development and Differentiation (Mario Mancino, Claudia Esposito, Raffaella Pasquale, Immacolata Vocca, and Francesca Pentimalli). SECTION III: EPIGENETICS AND GENE TRANSCRIPTION. 5 Epigenetic Control of Gene Transcription (Christian Bronner, Mayada Achour, Thierry Chataigneau,and Valerie B. Schini-Kerth). 6 Epigenetics, MicroRNAs, and Cancer: An Update (Giuseppe Russo, Andrew Puca, Francesco Masulli, Stefano Rovetta,Letizia Cito, Debora Muresu, Flavio Rizzolio, and Antonio Giordano). SECTION IV: EPIGENETICS AND CANCER. 7 The Role of Epigenetic Modifications in Cancer (Michael J. Powell, Vladimir M. Popov, Xiang Wang, Steven B. McMahon,Alexander Mazo, and Richard G. Pestell). 8 MBD4/MED1 Protein in DNA Repair and Demethylation, Cancer, and Other Diseases (Serena Buontempo, Mara Sannai, and Alfonso Bellacosa). 9 Epigenetics in Pediatric Cancers (Roberta Ciarapica, Lavinia Raimondi, Federica Verginelli, and Rossella Rota). 10 Epigenetic Mechanisms in Cancer Formation and Progression (Elisabetta Fratta, Luca Sigalotti, Alessia Covre, Giulia Parisi, Riccardo Danielli, Hugues Jean Marie Nicolay, Sandra Coral, and Michele Maio). SECTION V: EPIGENETICS AND ANTICANCER DRUG DEVELOPMENT AND THERAPY. 11 Recent Advances in the Field of Stem Cell Research: Toward the Definition of the Epigenetic and Genetic Codes of Pluripotency (Gaetano Romano). 12 Potential of Heat Shock Protein Targeting for Human Therapy (Laszlo Otvos, Jr). 13 Advances in Stem Cell Therapy for Cancer Research (Andrew Puca and Antonio Giordano). 14 Epigenetic Targets and Drug Development (Paraskevi Vogiatzi, Maria Irene Scarano, and Pier Paolo Claudio). Index.

Read more less